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CHAPTER 1: INTRODUCTION
1.1 Bacterial protein synthesis
Translation of genes into proteins happens in two steps. First, the DNA is transcribed
to messenger RNA (mRNA), a process that is catalyzed by RNA polymerase. Second,
the mRNA is translated into the encoded protein by a ribonucleoprotein complex called
the ribosome. Transfer RNA (tRNA) is the biomolecule that connects the genetic code to
the protein sequence. These tRNAs contain an anticodon that pairs with the codon in the
mRNA; the amino acid on the 3’ end of each tRNA matches the identity of the codon in
the mRNA.
Protein synthesis can also be described in two phases. In phase one, an aminoacyltRNA synthetase (aaRS) will pair its cognate amino acid with its cognate tRNA, in an
ATP-dependent manner, to form an aminoacyl-tRNA (aa-tRNA) (Figure 1.1A). This
reaction is generally selective because most aaRSs are specific for both the amino acid
and the tRNA and discriminate against other potential compounds in the pool of similarly
structured substrates. In phase two, the aa-tRNA forms a ternary complex with elongation
factor Tu (EF-Tu) and GTP that then binds to the ribosome where decoding of the mRNA
occurs, allowing for the polypeptide chain to continue to grow (Figure 1.1B) [1].

Figure 1.1
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Protein synthesis usually occurs with high accuracy for an organism to survive;
consequently, there must be twenty sets of correctly aminoacylated tRNAs to read all
mRNA codons [2]. Each aaRS catalyzes the esterification of its amino acid substrate to
its cognate tRNA in two steps. In the first step, the aaRS condenses the amino acid with
ATP to produce an enzyme-bound aminoacyl adenylate (aa-AMP), releasing inorganic
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pyrophosphate. In the second step, either the 2’ or 3’ hydroxyl group of the 3’ adenosine

Figure 1.2

in the tRNA reacts with this high-energy aa-AMP to produce the aa-tRNA (Figure 1.2) [3].
All aaRSs catalyze these same two reactions. Nevertheless, these enzymes are
separated into two classes (Class I and Class II) based on the structure of their active
sites [4, 5], offering an ancient example of convergent evolution. A more in-depth review
of the aaRSs will be discussed in Section 1.7.
R

ATP

PPi

O

H 3N

aaRS
O-

R

tRNAaa
O

H 3N

aaRS
O

AMP

AMP

R
O

H 3N
O

tRNAaa

Figure 1.2. Aminoacylation of tRNAs. In the first step, an aaRS reacts with its cognate
amino acid and ATP to produce an enzyme-bound aminoacyl adenylate (aa-AMP),
releasing inorganic pyrophosphate. In the second step, either the 2’ or 3’ hydroxyl group
of the 3’ adenosine in the tRNA reacts with the high-energy aa-AMP to produce the aatRNA [3].
of tRNAs. In the first step, an aaRS reacts with its
1.2Figure
Direct 1.2.
and Aminoacylation
indirect tRNA aminoacylation
cognate amino acid and ATP to produce an enzyme-bound aminoacyl adenylate (aaAMP), releasing
the there
secondare
step,
either the
2’ oracids,
3’
Previously,
it wasinorganic
generallypyrophosphate.
accepted that,Insince
20 conical
amino
hydroxyl group of the 3’ adenosine in the tRNA reacts with the high-energy aa-AMP
to produce
the20
aa-tRNA.
there
must be
aaRSs, one for each cognate amino acid-tRNA pair. While this

hypothesis is true for eukaryotes and select bacteria, such as Escherichia coli (E. coli), it
is generally not true for prokaryotes [4]. Organisms, like E. coli, that contain all 20 aaRSs
are able to directly aminoacylate their tRNAs with all 20 commonly encoded amino acids
(Figure 1.2) [3, 4]. For example, asparaginyl-tRNA synthetase (AsnRS) will aminoacylate
tRNAAsn with asparagine to produce Asn-tRNAAsn.
All archaea and many bacteria lack one or more aaRSs, which means they must use
an indirect path to aminoacylate some tRNAs [2, 6, 7]. Indirect tRNA aminoacylation
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proceeds via misacylated tRNAs, which presents a challenge for the fidelity of translation
of mRNA codons. Most microorganisms lack AsnRS or glutaminyl-tRNA synthetase
(GlnRS). Organisms that lack either aaRS must use a two-step, indirect pathway to
biosynthesize Asn-tRNAAsn and Gln-tRNAGln, respectively [2, 4, 7-10] (Figure 1.3). This
pathway utilizes a non-discriminating aspartyl-tRNA synthetase or a non-discriminating
glutamyl-tRNA synthetase (ND-AspRS and ND-GluRS) to misacylate Asp-tRNAAsn or
Glu-tRNAGln, respectively. (Red text indicates misacylation.) These two aaRSs are called
non-discriminating aaRSs because they have a relaxed specificity for tRNA and are able
to also misacylate tRNAAsn with Asp and tRNAGln with Glu, to produce Asp-tRNAAsn and
Glu-tRNAGln, respectively [6, 8, 10]. In bacteria, these misacylated intermediates are
converted into the correctly aminoacylated products, Asn-tRNAAsn and Gln-tRNAGln, by a
heterotrimeric glutamine-dependent amidotransferase called GatCAB [2, 7, 11] (Figure
1.3). An expanded discussion of GatCAB is the focus of Section 1.3.

Figure 1.3
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Figure 1.3. Indirect pathway for the aminoacylation of tRNAAsn and tRNAGln. NDAspRS and ND-GluRS produce the misacylated intermediates Asp-tRNAAsn and GlutRNAGln, respectively. Transamidation of these aminoacyl-tRNAs is achieved by an
amidotransferase, GatCAB [2, 4, 6-11].
Figure 1.3. Indirect pathway for the aminoacylation of tRNAAsn and tRNAGln. NDAspRS and ND-GluRS produce the misacylated intermediates Asp-tRNAAsn and GluOur lab studies indirect tRNA aminoacylation in 3 different pathogens; Helicobacter
tRNAGln, respectively. Transamidation of these aminoacyl-tRNAs is achieved by an
amidotransferase, GatCAB.
pylori (H. pylori), Staphylococcus aureus (S. aureus), and Mycobacterium smegmatis (M.
smegmatis) (Table 1.1). H. pylori was the first organism sequenced that lacked genes
that encoded both GlnRS and AsnRS [12]. H. pylori utilizes an ND-AspRS to misacylate
Asp-tRNAAsn, as discussed above [13]. However, H. pylori does not have an ND-GluRS,
instead it contains a non-cognate aaRS called GluRS2, which only produces Glu-tRNAGln,
and a cognate, discriminating aaRS called GluRS1, which can only biosynthesize GlutRNAGlu [9, 14]. GluRS2 is found in a small subset of bacteria. H. pylori also lacks
asparagine synthetase (AsnS), the enzyme responsible for the biosynthesis of
asparagine [12]. Organisms that lack AsnS use indirect tRNA aminoacylation to
synthesize asparagine in a tRNA-dependent manner [15]. For example, S. aureus has a
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functional AsnRS, but lacks AsnS; therefore S. aureus AspRS is non-discriminating and
is used in indirect tRNA aminoacylation to biosynthesize asparagine on tRNAAsn [16].
Table 1.1 Examples of microorganisms lacking one or more aaRSs. These
organisms use indirect tRNA aminoacylation.
Organism
Missing aaRS
Other relevant missing enzyme
H. pylori
AsnRS GlnRS AsnS
S. aureus
GlnRS AsnS
M. tuberculosis/ AsnRS GlnRS
smegmatis
1.3 GatCAB, the bacterial amidotransferase
Reproduced in part with permission from *Rathnayake, U. M., *Wood, W. N., and
Hendrickson, T. L. (2017) Indirect tRNA Aminoacylation During Accurate Translation and
Phenotypic Mistranslation, Curr Opin Chem Biol. 41, 114-122.
* These two authors contributed equally to this review article and are listed alphabetically.
Bacterial GatCAB is a heterotrimeric, glutamine-dependent amidotransferase (GAT)
composed of three subunits: GatA, GatB, and GatC, with two distal active sites in GatA
and GatB (~40 Å apart) [17]. GatCAB catalyzes three discrete reactions (glutamine
hydrolysis, phosphorylation, and transamidation) to convert both Asp-tRNAAsn and GlutRNAGln into Asn-tRNAAsn and Gln-tRNAGln, respectively (Reactions 1-3, shown for AsntRNAAsn biosynthesis only) [2]
Gln + H2O + ATP + Asp-tRNAAsn à Glu + ADP + H2Pi + Asn-tRNAAsn (Overall reaction)
Gln + H2O à Glu + +NH4

(Rxn 1, GatA)

Asp-tRNAAsn + ATP à γ-phosphoryl-Asp-tRNAAsn + ADP

(Rxn 2, GatB)

γ-phosphoryl-Asp-tRNAAsn + +NH4 à Asn-tRNAAsn + H2Pi

(Rxn 3, GatB)
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GatA is homologous to certain amidases [2] and catalyzes the hydrolysis of glutamine
to produce glutamate and ammonium (Rxn 1). The ammonium is shuttled into an
ammonia tunnel that connects the GatA and GatB active sites. (This tunnel is discussed
in greater detail below.) GatB catalyzes the ATP-dependent phosphorylation/activation of
Asp-tRNAAsn to γ-phosphoryl-Asp-tRNAAsn (Rxn 2). GatB then uses the ammonium
produced by GatA (deprotonated to ammonia via an unknown mechanism) to convert γphosphoryl-Asp-tRNAAsn to Asn-tRNAAsn (Rxn 3) [2, 7].
Many enzymes use molecular tunnels to deliver ammonia from a glutaminase active
site to a downstream active site [18, 19]. Prior to discovery of GatCAB, known ammonia
tunnels were typically hydrophobic and the common mechanistic assumption was that
ammonia was passively transferred in its neutral, deprotonated form (NH3), even through
tunnels with some hydrophilicity [19]. In sharp contrast, GatCAB’s ammonia tunnel, which
transfers ammonia ~40 Å from GatA to GatB, is lined with highly conserved polar and
ionic residues and is populated with many ordered water molecules [17]. The
hydrophilicity of GatCAB’s tunnel highlights the likelihood that this enzyme employs a
distinct and novel mechanism (compared to other GATs) to transfer ammonia from one
active site to another. It has been proposed that ammonia migrates through this tunnel
by interchanging between neutral ammonia and the protonated ammonium cation with
the tunnel side chains possibly acting as acids and bases [17].
Two ammonia tunnels in S. aureus GatCAB have been proposed, which will be
referred to as tunnel I [17] and tunnel II [20], in order of their discovery. Tanaka and
coworkers proposed tunnel I, in which ammonia delivery through the GatCAB tunnel
would proceed through a series of protonation and deprotonation steps (Figure 1.4A)
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[17]. Ammonia transport would rely on the polar and ionic residues and water molecules
in the GatCAB tunnel acting as general acids or bases for proton relay and as stabilizers
for hydrogen bond formation. Ammonium (+NH4) would be deprotonated to ammonia
(NH3) and then protonated back to ammonium repetitively until it reached the GatB active
site as ammonia (via deprotonation near the end of the tunnel or in the GatB active site
by an unknown base) [17]. This novel mechanism would distinguish GatCAB from other
GATs by requiring discrete catalytic steps to occur within the ammonia tunnel [18, 19].
Using the H. pylori GatCAB, our lab mutated several amino acids that line ammonia tunnel
I and performed in vitro kinetic analyses on wild-type and mutant GatCAB variants [21].
Mutations near the GatA active site and lining the tunnel (T149A in GatA) and at the
interface of GatA and GatB (K89R in GatB) caused reductions in the phosphorylation
kinetics of GatB, indicating there may be interdomain communication. Molecular
dynamics simulations using S. aureus GatCAB (by Cisneros and Dewage) further
supported this scenario and led to the identification of a subset of residues in GatCAB
that likely participate in interdomain communication [21].
Using computational methods, Tateno and co-workers proposed tunnel II, which
begins with a hydrophobic entrance into the tunnel from GatA (not shown) [20]. Tunnels
I and II converge ~10 Å from the glutaminase active site. Dewage and Cisneros recently
calculated the potentials of mean force for the passive transport of ammonia along both
tunnels in S. aureus GatCAB through molecular dynamic stimulations [22]. The free
energy calculations were much lower for tunnel I than for tunnel II. Their results [22],
combined with those from mutagenesis [21], argue that tunnel I is the functionally relevant
tunnel.
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We went on to identify a catalytic residue in tunnel I as a probable catalytic base to
first deprotonate ammonium, directing the resultant ammonia to the next location in the
tunnel (Figure 1.4B) [23]. D185 was identified in GatA (H. pylori numbering), located near
the T149 entrance residue (Figure 1.4A). D185A and D185N GatCAB mutants showed
reductions in glutamine hydrolysis and phosphorylation compared to WT GatCAB, while
their transamidation activities were almost completely disrupted. D185 lies near the top
of tunnel I (past the branching point from tunnel II) providing additional support for
GatCAB’s probable use of tunnel I over tunnel II. Most GATs contain largely hydrophobic
ammonia tunnels and the mechanistic consensus is that ammonia remains deprotonated
as it migrates through these different tunnels. GatCAB is the first example of a GAT with
a hydrophilic tunnel. And, to our knowledge, D185 is the first example of a residue that
serves any direct catalytic role in an ammonia transport tunnel [23]. This discovery offers
direct evidence for a novel mechanism for ammonia transfer through the GatCAB tunnel
via a series of protonation and deprotonation steps.

Figure 1.4
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Indirect tRNA aminoacylation and GatCAB play an important role in translational
fidelity. Normally, the role of GatCAB is to correct the misacylation of Asp-tRNAAsn and
Glu-tRNAGln to maintain the fidelity of translation. However, Javid and coworkers have
demonstrated via forward genetic screens that mutations in GatA lead to mistranslation
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of asparagine and glutamine codons and that these errors can result in an adaptive
phenotype [25]. They observed that mutations in GatA not only resulted in reduced
activity of GatCAB but also decreased its expression levels. These mutations also
increased rates of mistranslation. Specifically, an aspartate insertion at an asparagine
codon in RNA polymerase, a residue that is important for rifampicin binding in RNAP,
resulted in the bacterium becoming tolerant to rifampicin [25]. Javid and coworkers
research demonstrates that the indirect tRNA aminoacylation pathway can be redirected
under stressful growing environments to allow for low levels of mistranslation at
asparagine and glutamine codons to be used as a survival mechanism [25, 26].
1.4 The Asn-transamidosome
Organisms that use indirect aminoacylation must also prevent the two misacylated
tRNA intermediates, Asp-tRNAAsn and Glu-tRNAGln, from entering the ribosome where
they could cause detrimental translational errors [13, 27, 28]. One mechanism is
discrimination against misacylated tRNAs by EF-Tu [29-31]. However, this alone, cannot
completely safeguard the genetic code from mistranslation of asparagine and glutamine
codons for aspartate and glutamate, respectively [13, 27]. Another mechanism relies on
the formation of a transamidosome, a ribonucleoprotein complex that promotes the
conversion of these misacylated tRNAs to their correctly aminoacylated tRNAs, while
sequestering each misacylated tRNA from EF-Tu and the ribosome [32-34]. For example,
in Thermus thermophilus (T. thermophilus), the Asn-transamidosome, comprised of two
ND-AspRS, four tRNAAsn, and two GatCAB molecules, simplifies the transfer of AsptRNAAsn from ND-AspRS to GatCAB, presumably limiting misuse of Asp-tRNAAsn in
translation (Figure 1.5) [32, 33]. The beauty of this structure is that the acceptor arm of
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tRNAAsn lies in the active site of ND-AspRS where it will be misacylated to Asp-tRNAAsn;
the acceptor arm can easily rotate into the active site of GatB where it will be
phosphorylated and transamidated to Asn-tRNAAsn [32, 33]. This Asn-transamidosome
structure contains four tRNAAsn molecules, two are catalytic and two are scaffolding
(Figure 1.5). The two scaffolding tRNAAsn help keep the entire structure together once
the two catalytic tRNAAsn have been converted to Asn-tRNAAsn, when the latter leave the
transamidosome and go on to the ribosome to be used for translation [33].

Figure 1.5
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Efforts to isolate an analogous H. pylori Asn-transamidosome proved to be
unsuccessful [35, 36]. This observation led to the hypothesis that another protein may be
required for stable H. pylori Asn-transamidosome complex formation. Our lab discovered
a protein of unknown function called Hp0100 by mining a published yeast two-hybrid
assay that mapped out the protein-protein interaction profile of H. pylori [37]. In this
screen, the likelihood that an observed interaction between two proteins was functionally
relevant was described by a scoring system, ranging from A through E. An A score
indicates that the observed interactions are likely to be physiologically relevant in H. pylori
and a score of E suggests that the observed interaction is an artifact or noise in the two-
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hybrid assay. In the originally reported protein-protein interaction profile, H. pylori NDAspRS was given a B score with Hp0100. Hp0100 showed only weak, transient, or
erroneous interactions with GatA, one of the two large subunits of GatCAB; this
interaction was given a D score (Figure 1.6). Since ND-AspRS and GatCAB have

Figure 1.6

functional connections [2, 8], we decided to investigate Hp0100 with respect to its
apparent interactions with H. pylori ND-AspRS and H. pylori GatCAB.
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Figure 1.6. Yeast two-hybrid protein-protein interaction profile of key proteins in H.
pylori. The interaction between ND-AspRS and Hp0100 was given a B score, whereas
the interaction between GatCAB and Hp0100 was given a D score [37].
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Transfer RNAAsn is misacylated to Asp-tRNAAsn, which is then converted to Asn-tRNAAsn
by GatCAB. Then, Asn-tRNAAsn is released from the complex to be used by the ribosome
for translation (Figure 1.7) [34]. It was also observed that Hp0100 increases the catalytic
efficiency of GatCAB by ~35-fold with Asp-tRNAAsn as a substrate [34] and ~3-fold with

Figure 1.7

Glu-tRNAGln as a substrate (unpublished data, ref. Dr. Gayathri Silva’s thesis [38]).
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1.5 Hp0100, an ATPase with two different active sites
In our initial efforts to characterize Hp0100, Dr. Gayathri Silva discovered that the
protein sequence and structural model contained two putative ATP-binding motifs. The
first is an a-adenosine nucleotide hydrolase (AANH) [39] domain. Interestingly, when the
model of Hp0100 was generated by Rosetta [40], it was built from a structure of
argininosuccinate synthetase, which contains an N-type ATP pyrophosphatase motif that
also belongs to the AANH superfamily (cd01986) [39, 41, 42]. Typically, the AANH ATPbinding motif hydrolyzes ATP to AMP and pyrophosphate. We have unpublished data
from assays performed with Hp0100 and either Asp-tRNAAsn or Glu-tRNAGln and a-32PATP, where thin layer chromatography (TLC) was used to separate a-32P-ATP, a-32PADP, and a-32P-AMP. Surprisingly, the production of ADP was observed instead of AMP,
indicating that the AANH-like domain in Hp0100 is an ATPase that hydrolyzes ATP to
ADP and Pi [38].
The second putative ATP-binding motif is a P-loop nucleotide-binding motif. This
ATPase site was discovered from the primary sequence, because P-loops have a
conserved consensus sequence of GXXXXGK[S/T] [43]. P-loops are generally involved
in the hydrolysis of the b-g-phosphate of ATP, i.e. ATP is hydrolyzed to ADP and Pi [43].
Dr. Silva made several point mutations in both the AANH domain and the P-loop. The
mutants were then assayed for ATPase activity using an enzyme-coupled assay [21].
Intriguingly, mutations in the AANH domain showed a reduction in activity with GlutRNAGln, compared to its activity with Asp-tRNAAsn. In contrast, mutations made in the Ploop domain showed a reduction in activity with Asp-tRNAAsn, compared to its activity with
Glu-tRNAGln [38]. Thus, Hp0100 contains two distinct ATPase sites that are activated by
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different misacylated-tRNAs: the first is an AANH-like domain that is activated by GlutRNAGln; the second is a P-loop motif that is activated by Asp-tRNAAsn, indicating that
Hp0100 is the first ATPase with two distinct active sites that are activated by two different
substrates.
Chapter 2 of this thesis focuses on the initial characterization of an ortholog of Hp0100
from S. aureus, called Sa2591. Full-length orthologs of Hp0100 are restricted to the eproteobacteria clade; truncated versions, compromising the first 2/3 of the N-terminus of
Hp0100, are found outside of this clade. In Chapter 2, the ATPase activity of Sa2591 is
investigated and the results suggest that Sa2591 is a functional ortholog of Hp0100.
1.6 Sa2591 metal binding and a probable tRNA modifying enzyme
The primary sequence of Sa2591 contains a CXXC motif, a known metal-binding
domain, near the P-loop ATPase domain [44-46]. A model of Sa2591 was generated
using I-TASSER [47], which showed several other cysteine residues clustered near the
CXXC motif. Chapter 3 of this thesis focuses on characterizing the metal binding of
Sa2591 and investigating this protein as a probable epoxyqueuosine reductase, renaming
Sa2591 as QueH.
Recently, through comparative genomics, de Crécy-Lagard and coworkers
identified members of the domain of unknown function 208 (DUF208) family, including
Hp0100, Sa2591, and their orthologs, as putatively being involved in queuosine
biosynthesis [48]. Queuosine is a hypermodifed guanosine base found in 4 different
tRNAs: tRNAAsn, tRNAAsp, tRNAHis, and tRNATyr [49] in bacteria and eukaryotes. However,
only bacteria are able to biosynthesize queuosine. (Eukarya acquire this base from their
environment [49].) In bacteria, de novo synthesis of queuosine is a multistep process.
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The first 5 steps convert guanosine triphosphate (GTP) to 7-aminomethyl-7deazaguanine (preQ1). The last 3 steps occur on the target tRNA [50, 51]. Transfer RNAguanine transglycosylase (TGT) catalyzes the exchange of guanine at position 34 in
target tRNAs with preQ1. Next, S-adenosylmethionine ribosyltransferase-isomerase
(QueA) catalyzes the reaction of preQ1 to epoxyqueuosine (oQ). The final step is the
reduction of oQ to Q, which is achieved by QueG, a cobalamin-dependent
epoxyqueuosine reductase (Figure 1.8) [51, 52]. QueG also contains 2 [4Fe-4S] ironsulfur clusters that are used as a redox chain for the reduction of epoxyqueuosine after
cobalamin has nucleophilically opened the epoxide ring [53, 54].

Figure 1.8
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Many microorganisms lack QueG, but contain TGT, QueA, and queuosine in their
tRNAs, which led de Crécy-Lagard and coworkers to identify DUF208 as a putative, nonorthologous replacement for QueG [48]. This group demonstrated by in vivo
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complementation that DUF208 family members can restore queuosine biosynthesis in a
∆QueG E. coli strain [48]. Both Hp0100 and Sa2591 were tested in this work and
successfully restored queuosine production. These authors proposed naming the
DUF208 proteins QueH [48]. de Crécy-Lagard and coworkers did not detect any
cobalamin associated with QueH, suggesting that QueH uses a mechanism for
epoxyqueuosine reduction that is distinct from QueG [48].
Interestingly, two of the protein structures that were used as threading templates by ITASSER to generate the model of Sa2591 are tRNA modifying enzymes [47]. The two
structures are both of 2-thiouridine synthetase (TtuA) from two different organisms, the
hyperthermophilic archeon Pyrococcus horikoshii (P. horikoshii) and T. thermophilus [45,
46]. TtuA is responsible for the biosynthesis of 2-thioribothymidine (S2T) at position 54,
which is found in nearly all tRNAs in thermophilic and hyperthermophilic prokaryotes.
S2T54 is in the TYC loop and is necessary to stabilize the tRNA at the elevated growth
temperatures of thermophiles [55, 56]. TtuA belongs to the TtcA protein family, which are
characterized by having a P-loop ATPase domain and a CXXC metal binding motif near
each other [44, 56]. While TtuA is the tRNA modifying enzyme and contains sulfur
transferase activity, there are several other enzymes involved in the biosynthesis of S2T.
First, the C-terminus of a ubiquitin-like sulfur carrier protein called TtuB must be thiolated
to become a thiocarboxylate. This reaction is achieved by a persulfide that is generated
from a cysteine by a cysteine desulfurase [56]. TtuA uses the activated sulfur from the
thiocarboxylate for sulfur transfer; however, how the activated sulfur atom is transferred
from TtuB to TtuA has yet to be elucidated (Figure 1.9) [45, 46, 56]. Before sulfur transfer,

Figure 1.9
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TtuA uses its P-loop ATPase domain to adenylate the C2 oxygen in the carbonyl of the
ribothymidine in the tRNA to activate it for sulfur transfer (Figure 1.9) [46].
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participate in S2T biosynthesis [45]. They demonstrated activity in vivo because in vitro
reconstitution of functional protein had not yet been achieved. Tanaka and coworkers
eventually observed a [4Fe-4S] cluster in the crystal structure of TtuA [46]. This iron-sulfur
cluster is coordinated by 3 highly conserved cysteine residues, the same 3 cysteines
implicated by Yokoyama and colleagues for their mechanistic importance. Tanaka and
coworkers showed that in vitro activity of TtuA requires the oxygen-labile [4Fe-4S] ironsulfur cluster for S2T synthesis [46].
The structural similarities between Sa2591 (S. aureus QueH) and TtuA give insight
into the mechanism that Sa2591 may use for the reduction of epoxyqueuosine to
queuosine. This information is important because QueH is not homologous to QueG and
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does not contain cobalamin, therefore it must use a different epoxyqueuosine reduction
mechanism. In Chapter 3 of this thesis, the metal-binding features and epoxyqueuosine
reductase activity of Sa2591 are investigated and a mechanism is proposed for this
reaction.
1.7 The aminoacyl-tRNA synthetases
Chapter 4 focuses on an unexpected discovery that many bacterial aaRSs can
hydrolyze ATP to ADP and Pi in the presence of deacylated tRNA. Previously the aaRSs
were only known to catalyze the same two reactions (Figure 1.2, above) [3]. The first
reaction uses ATP to produce an enzyme-bound aa-AMP, releasing inorganic
pyrophosphate (PPi). In the second reaction, either the 2’ or 3’ hydroxyl group of the 3’end of the tRNA acts as a nucleophile to attack the a-carbonyl of the amino acid, releasing
AMP and producing the aa-tRNA.
Whether the 2’ or 3’ hydroxyl group of the tRNA is used in the second step of tRNA
aminoacylation depends on the class of aaRS. As mentioned above, the aaRSs are
divided into two classes, class I and class II, depending on the structures of their active
site [4, 5, 57]. Class I aaRSs have an active site Rossmann fold and Class II aaRSs have
a seven-stranded antiparallel b-sheet tertiary fold. The two different classes approach the
tRNA from different sides: Class I binds the minor groove of the acceptor steam and Class
II bind the major groove [4, 5]. These two classes can be further categorized into
subclasses based on structural and functional idiosyncrasies (Table 1.2) [4, 5, 57].
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Table 1.2 Classification of the aaRSs.1
Class I aaRSs
ArgRS
CysRS
IleRS
LeuRS
MetRS
ValRS
GlnRS
GluRS

Subclass
1a
1a
1a
1a
1a
1a
1b
1b

Class II aaRSs
AlaRS
GlyRS
HisRS
ProRS
SerRS
ThrRS
AsnRS
AspRS
LysRS
PheRS

Subclass
2a2
2a2
2a
2a
2a
2a
2b
2b
2b
2c

TrpRS
1c
TyrRS
1c
1
Standard three letter amino acid codes are used to abbreviate each aaRS.
2
AlaRS and GlyRS have been classified as Class 2a by some [4, 5, 57] and Class 2c by
others [4, 5]. We’ve chosen to identify them as Class 2a, based on similarities between
the structures of their active sites [57].
The aaRSs must be able to differentiate between pools of substrates that are
chemically similar to one another to ensure accurate translation of the proteome [1, 4, 5,
58]. An aaRS must choose the correct amino acid and the correct tRNA that are both
cognate to that particular aaRS. For example, IleRS must correctly select for both
isoleucine and tRNAIle. Since many of the amino acids have similar shapes and sizes and
all tRNAs have a similar secondary structure, the aaRS have evolved several different
strategies to circumvent the challenge of selecting both cognate amino acid and tRNA [4,
5, 58]. Some aaRSs have also evolved mechanisms to recognize a misacylatedadenylate or misacylated-tRNA and will hydrolyze this incorrect product. Some of these
different strategies that the aaRSs use to ensure accurate aminoacylation will be
discussed below.
The aaRSs primarily use 3 main regions of the tRNA for recognition: the discriminator
base at position 73, the acceptor stem, and the anticodon trinucleotide [4, 5, 58]. Transfer
RNAs typically contain several identity elements that are specific for their tRNA-aaRS
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pair. For example, tRNAAla contains a unique G3-U70 wobble base pair that AlaRS uses
to distinguish it from other tRNAs [59]. Some tRNAs also contain antideterminants that
are used to prevent tRNA binding to a non-cognate aaRS. For anticodon recognition,
many aaRS have an anticodon binding domain that makes significant contacts with the
cognate tRNA anticodon [4, 5, 58]. Transfer RNAs have also evolved to have modified
nucleotides, like queuosine, which increase their chemical diversity [60]. The aaRSs use
a combination of these different recognition elements to choose their cognate tRNA(s)
over other, non-cognate tRNAs.
The specificity of an aaRS for its cognate amino acid is also important for accurate
translation of the genome [1, 4, 5, 58]. Some aaRSs are able to exclude other amino
acids from their active site based on the structure and size of the amino acid alone.
However, this substrate selection can be difficult for some aaRSs when similar noncognate amino acids are present. For example, IleRS cannot completely discriminate
between Ile, its cognate amino acid, and valine. Therefore, some aaRSs, like IleRS, have
evolved proofreading capabilities to eliminate non-cognate amino acids that have been
activated as activated aa-AMPs or even aminoacylated onto the incorrect tRNA [4, 5, 58,
61]. These two proofreading mechanisms are called pre-transfer editing and post-transfer
editing, respectively (Figure 1.10). In pre-transfer editing, the aa-AMP is typically
transferred to a distinct editing site in the aaRS, where the non-cognate amino acid is
hydrolyzed from AMP. Post-transfer editing involves the hydrolysis of an amino acids that
has been misacylated onto the tRNA; this reaction is also catalyzed in a distal active site.
Figure 1.10 shows an example of these reactions for IleRS, which has both pre- and
post-transfer editing capabilities for the misactivation and misacylation of valine onto
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Figure 1.10

tRNAIle [4, 61-64]. The fidelity of translation is dependent on the specificity of the aaRSs
to select for the correct substrates. These enzymes use a combination of different
mechanisms to recognize their cognate tRNA and amino acid and, in certain cases when
this has failed, some aaRSs are able to edit misacylated products.
tRNAIle

PPi
IleRS + Val + ATP

IleRS:Val-AMP
Pre-transfer
editing

H2O

Val + AMP

IleRS + Val-tRNAIle + AMP
Post-transfer
editing

H2O

Val + tRNAIle

Figure 1.10. Editing functions of IleRS. Valine can be adenylated by IleRS resulting in
Val-AMP, which will be moved to the pre-transfer editing site where it will be hydrolyzed.
If tRNAIle binds to IleRS and becomes misacylated to Val-tRNAIle this will be hydrolyzed
by a post-transfer editing mechanism [4, 61-64].
Figure 1.10. Editing functions of IleRS. Valine can be adenylated by IleRS
The main function of the aaRSs is to aminoacylate tRNAs for ribosomal translation.
resulting in Val-AMP, which will be moved to the pre-transfer editing site where it will
be hydrolyzed. If tRNAIle binds to IleRS and becomes misacylated to Val-tRNAIle this
The aaRSs and aa-tRNAs also have different alternative functions within the cell [4, 5,
will be hydrolyzed by a post-transfer editing mechanism.

58]. Aminoacyl-tRNAs can act as amino acid donors in several different processes in the
cell, for example to regulate their own gene expression. Examples include: AlaRS binding
to its own DNA to prevent transcription [65]; PheRS regulating transcription of the pheS
gene [66]; and ThrRS regulating translation of itself by a feedback mechanism [67].
GluRS can be phosphorylated and, through a cascade of different responses, is linked to
bacterial persister formation [68]. Deacylated tRNAs can also act as important signaling
molecules during amino acid starvation. When the concentration of deacylated tRNAs
rises in the cell, the stringent response is turned on, which signals for the upregulation of
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enzymes involved in amino acid biosynthesis. Defective aaRS editing functions can have
a direct effect on the stringent response [69].
The aaRSs were first characterized in the 1950s and were long thought to only have
one function in the cell: To aminoacylate tRNAs for translation. As discussed above,
aaRSs, aa-tRNAs, and even deacylated tRNAs are involved in a diverse array of cellular
functions. Chapter 4 of this thesis focuses on our discovery of a new, unprecedented
reaction catalyzed by some aaRSs. We demonstrate that some aaRSs hydrolyze ATP to
ADP and Pi in the presence of deacylated tRNAs. We screened 25 different aaRSs from
3 different bacterial species for this activity. In Chapter 4, we make comparisons of rates
for this activity among the different sub-classes of aaRSs and across species. We also
discuss different possible roles of this ADP production including a tantalizing possible
connection to bacterial persistence.
In conclusion, this thesis describes two research projects that are connected by the
common theme of tRNA aminoacylation. Chapters 2 and 3 examine Sa2591 for its roles
in indirect tRNA aminoacylation and, potentially, in queuosine biosynthesis. Chapter 4
describes the discovery that many aaRSs can produce ADP in the presence of deacylated
tRNA. The impact of these discoveries will be discussed independently in each chapter
and more broadly in Chapter 5.
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CHAPTER 2: A NOVEL PROTEIN FROM STAPHYLOCOCCUS AUREUS, SA2591, IS
SIMILAR TO HP0100 IN STRUCTURE AND PROBABLE FUNCTION
2.1 Introduction
Protein synthesis typically occurs with high accuracy [2]; consequently, there must be
twenty sets of correctly aminoacylated tRNAs to read all mRNA codons. However,
Helicobacter pylori, Staphylococcus aureus, and many other microorganisms lack one or
more aminoacyl-tRNA synthetase (aaRS), the enzymes that typically catalyze the
esterification of each amino acid to their cognate tRNAs prior to ribosomal translation [3,
12, 70]. Many microorganisms lack glutaminyl-tRNA synthetase (GlnRS) and/or
asparaginyl-tRNA synthetase (AsnRS) [3]. These species use an indirect path to correctly
aminoacylate tRNAGln and/or tRNAAsn to produce Gln-tRNAGln and Asn-tRNAAsn [2, 4, 7].
Indirect tRNA aminoacylation is a two-step pathway that begins with tRNA
misacylation (step 1), followed by aminoacyl-tRNA transamidation (step 2) to produce the
desired products (Figure 1.3) [7]. Misacylation of tRNAAsn is achieved by a nondiscriminating aspartyl-tRNA synthetase (ND-AspRS), which produces both Asp-tRNAAsp
and Asp-tRNAAsn [6, 13]. Glu-tRNAGln is generated by either a non-discriminating
glutamyl-tRNA synthetase (ND-GluRS, which also makes Glu-tRNAGlu) [10] or a tRNAGlnspecific GluRS2 [9, 14]. The conversion of these misacylated tRNAs (Asp-tRNAAsn and
Glu-tRNAGln) into the corresponding correctly aminoacylated tRNAs (Asn-tRNAAsn and
Gln-tRNAGln) is achieved by an amidotransferase called GatCAB [2, 4, 11]. In bacteria,
GatCAB is typically heterotrimeric [2].
In some organisms (e.g. T. thermophilus), ND-AspRS and GatCAB assemble into a
tRNAAsn-dependent ribonucleoprotein complex called the Asn-transamidosome (Figure
1.5). This complex promotes the conversion of Asp-tRNAAsn to Asn-tRNAAsn [32, 33].
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However, efforts to isolate an analogous H. pylori Asn-transamidosome have been
unsuccessful [35, 36]. Instead, a tRNA-independent Asn-transamidosome assembles via
an unusual protein factor called Hp0100 [34].
Our lab previously discovered H. pylori Hp0100, via data-mining of a yeast two-hybrid
assay (Figure 1.6) [37]. We showed that this protein is required for the tRNA-independent
H. pylori Asn-transamidosome (Figure 1.7) [34]. Hp0100 accelerates the transamidation
rate of GatCAB for Asp-tRNAAsn by ~35-fold [34] and for Glu-tRNAGln by ~3-fold
(unpublished data, ref. Dr. Gayathri Silva’s thesis [38]). We also have remarkable
unpublished data (Dr. Gayathri Silva [38]) that show that Hp0100 contains two divergent
ATP hydrolase (ATPase) active sites: the first is an a-adenosine nucleotide hydrolase
(AANH) [39] domain that is activated by Glu-tRNAGln; the second is a P-loop motif [43],
wherein ATP hydrolysis is activated by Asp-tRNAAsn. Results from Dr. Gayathri Silva’s
work on Hp100 is summarized in Figure 2.1 [38]. To our knowledge, this is the first
ATPase to contain two distinct active sites that are stimulated by two different substrates.
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proteins involved in central processes like tRNA aminoacylation remain undiscovered.
Our results also show that the biosynthesis of aminoacylated tRNAs in H. pylori is more
complex than previously appreciated. Our lab’s discovery of Hp0100, its interactions with
ND-AspRS and GatCAB, and its impact on GatCAB efficiency offer a precedent for the
hypothesis that proteins of unknown function can still be discovered to be involved in
tRNA aminoacylation. Our published [34] and unpublished data [38] are summarized in
Figure 2.1.
While full-length orthologs of Hp0100 are unique to the e-proteobacteria, truncated
versions, comprising approximately 2/3 of the primary sequence of Hp0100, have been
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found in many different bacteria. Notably, examples of this new variation were identified
in Neisseria gonorrhoeae (N. gonorrhoeae) and S. aureus, which are both listed by the
CDC as “biggest threats” to the US [71, 72]. The primary sequences of these proteins all

Figure 2.2

contain the two ATPase active sites identified in Hp0100: the AANH domain [39] and a
P-loop motif [43] (Figure 2.2).
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The main focus of this chapter is to describe our efforts to characterize indirect tRNA
aminoacylation in methicillin-resistant S. aureus (MRSA). MRSA is resistant to first-line
antibiotics and is a cause for healthcare-associated bloodstream and catheter-related
infections [71]. MRSA has a viable copy of AsnRS, but it lacks GlnRS, so indirect tRNA
aminoacylation is required for the biosynthesis of Gln-tRNAGln. This pathogen is also
missing a gene coding asparagine synthetase (AsnS), the protein that would normally
biosynthesize asparagine [70]. The absence of AsnS indicates that indirect tRNA
aminoacylation will utilize ND-AspRS and GatCAB for tRNA-dependent asparagine
biosynthesis [16]. And, most importantly, MRSA contains a truncated ortholog of Hp0100,
called Sa2591. We hypothesize that Hp0100 and Sa2591 are functional orthologs,
despite their different sizes. Sa2591 has proven to be much easier to work with because
it expresses and purifies from E. coli more readily. When purifying Hp0100, a large portion
of the protein remains insoluble, which may be due to the extra domain on the C-terminus
of Hp0100 that is lacking in Sa2591. For these reasons, we set out to evaluate Sa2591
to verify that it is structurally and functionally related to Hp0100.
A cartoon highlighting the identifiable sequences and features of Sa2591 is compared
to Hp100 in Figure 2.2A. Sa2591 consists of the first 2/3 of Hp0100, including both the
AANH and P-loop ATPase domains. Both Hp0100 and Sa2591 contain several conserved
cysteine residues that form a putative metal-binding site. This site is the focus of Chapter
3 and will be discussed in more detail there. Comparative sequence alignments of the
AANH domain and P-loop motifs are show in Figure 2.2B. Overall, these two orthologous
proteins share 29% sequence identity [73]. Structural models of Hp0100 and Sa2591
were generated using Rosetta [40] and I-TASSER [47], respectively. As expected, the
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two models showed structural similarity (Figure 2.3). These similarities led us to
hypothesize that Sa2591 may function in a similar way to Hp0100.
A. Overlay of Hp0100 (gray)
and Sa2591 (cyan) models

B. AANH domain

C. P-loop domain

Figure 2.3. Structural alignment of Hp0100 and Sa2591. A. Structural alignment of
Hp0100 (gray) and Sa2591 (cyan). B. Close-up of the alignment of the two AANH
domains. C. Close-up of the alignment of the two P-loop domains. Rosetta [40] was used
to generate the model of Hp0100 and I-TASSER [47] was used to generate the model of
Sa2591.
2.2 Results
2.2.1 E. coli AspRS co-purifies with His6-Sa2591
Figure 2.3. Structural alignment of Hp0100 and Sa2591. A. Structural alignment of
Hp0100 (gray) and Sa2591 (cyan). B. Close-up of the alignment of the two AANH
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chromatography
after His6-Hp0100 was overexpressed in E. coli [38]. To begin to test our
Sa2591.
hypothesis that Sa2591 is a functional ortholog of Hp0100, we purified His6-Sa2591 and
looked for co-purification of E. coli AspRS. The sa2591 gene was codon optimized for
expression in E. coli and cloned into a vector with an N-terminal 6-histidine (His6) tag. A
TEV protease cleavage site was added between the His6 tag and the start codon of
Sa2591 so that the His6 tag could be removed for downstream experiments. His6-Sa2591
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was overexpressed in E. coli and purified by nickel affinity chromatography and TEV
protease was added to remove the His6 tag. The protein was further purified by size
exclusion chromatography (SEC). A co-purifying protein was observed that is
approximately the size of E. coli AspRS (~66 kDa) (Figure 2.4A, Sample 1). This
observation suggested that the non-covalent interactions between these two proteins are
strong. An aminoacylation assay with tRNAAsp was performed, which suggested that the
66 kDa protein was E. coli AspRS (Figure 2.4B, Sample 1, black line). A later fraction of
Sa2591 did not contain detectible levels of AspRS (Figure 2.4A, Sample 2) nor did it
robustly aminoacylate tRNAAsp (Figure 2.4B, Sample 2, blue line). These results
suggests that Sa2591 and E. coli AspRS form a complex in vivo and offered the first
indication that Sa2591 might be a functional ortholog of Hp0100.
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transcripts.
To further investigate if Sa2591 is a functional ortholog of Hp0100, Sa2591 was
assayed for ATPase activity using an enzyme-coupled assay to specifically detect ADP
production. This continuous, spectrophotometric assay provides initial rates for ATP
hydrolysis to ADP and Pi [21]. ADP production is coupled to NADH oxidation via pyruvate
kinase and lactate dehydrogenase with phosphoenolpyruvate and NADH as substrates,
respectively. A decrease in absorbance at 340 nm indicates NADH oxidation and is
directly correlated to ADP production (Figure 2.5A). Importantly, oxidation of NADH does
not occur in the presence of either ATP or AMP (Figure 2.5B), demonstrating that this

35
assay is specific for ADP. This assay was used to monitor Sa2591 for ADP production in
the absence of tRNA and in the presence of misacylated tRNAs and correctly
aminoacylated tRNAs from two different sources: tRNAs overexpressed in vivo versus
those transcribed in vitro. The in vivo transcribed tRNAs were obtained by overexpressing
the specific S. aureus tRNA isoacceptor in E. coli. These tRNAs possibly contain critical
post-transcriptional modifications on the tRNA however these samples are contaminated
with total E. coli tRNA. (There is no good way of separating the overexpressed S. aureus
tRNA from the E. coli tRNA during purification.) In vitro transcribed tRNA was also used
because this allows us to be confident that only S. aureus tRNA is in the sample, however
these tRNAs lack all post-transcriptional modifications and the importance of these
modifications to Hp0100 and Sa2591 function remains untested.
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tRNA (Figure 2.6A and B). Figure 2.6A shows the data for Sa2591 alone (black) and
with either misacylated Asp-tRNAAsn (green) or Glu-tRNAGln (purple). The observed
decrease in absorbance at 340 nm is observed for both assays with Asp-tRNAAsn and
Glu-tRNAGln compared to Sa2591 alone, indicating that ATP is hydrolyzed to ADP and Pi,
specifically in the presence of these misacylated tRNAs. Figure 2.6B shows the data for
Sa2591 with overexpressed tRNAs that have been correctly aminoacylated (Asp-tRNAAsp
(blue) versus Glu-tRNAGlu (red)); these aminoacyl-tRNAs do not stimulate ATPase activity
compared to Sa2591 alone (black). These results are consistent with those we’ve
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previously observed with Hp0100 [38]. In contrast, ATPase assays with misacylated AsptRNAAsn and correctly aminoacylated Asp-tRNAAsp from in vitro transcribed tRNAs
showed minimal stimulation by Asp-tRNAAsn (Figure 2.6C). The observation that AsptRNAAsn from in vivo transcribed tRNA does stimulate the ATPase activity of Sa2591 and
Asp-tRNAAsn from in vitro transcribed tRNA suggests that modifications on tRNAAsn are
necessary for this activity. Additional experiments will need to be conducted to confirm
this hypothesis.
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2.3 Discussion
Many microorganisms do not contain a full set of twenty aaRSs. When AsnRS or
GlnRS is missing, these species must use an indirect pathway to aminoacylate tRNAAsn
and tRNAGln [3, 4]. The intermediate products in this indirect tRNA aminoacylation
pathway are misacylated tRNAs (Asp-tRNAAsn and/or Glu-tRNAGln). Microorgansisms that
use this pathway must prevent these misacylated tRNAs from entering the ribosome
where they could cause translational errors that could be detrimental to the cell [2]. One
way that cells prevent Asp-tRNAAsn from entering the ribosome is through the formation
of a ribonucleoprotein complex, called the Asn-transamidosome. When our lab
discovered Hp0100, we hypothesized that this protein may drive Asn-transamidosome
formation in H. pylori and, in fact, it is required for formation of a stable, tRNA-independent
Asn-transamidosome (Figure 1.7) [34]. Hp0100 increases the transamidation rates of
GatCAB with both Asp-tRNAAsn and Glu-tRNAGln as substrates. Hp0100 is also an
ATPase with two distinct active sites that are stimulated by two different misacylated
tRNAs [34, 38]. To our knowledge, this is the first ATPase to contain two distinct active
sites that are activated by two different substrates.
We recently discovered a truncated ortholog of Hp0100 in S. aureus, called Sa2591.
Because of their sequence and structural similarities we hypothesized that Sa2591 is a
functional ortholog of Hp0100. When we were first studying Sa2591, we observed that a
protein about the size of E. coli AspRS (~66 kDa) co-purified with Sa2591 (Figure 2.4A)
through Ni2+ and size exclusion chromatography. An aminoacylation assay was
performed with the co-purifying protein and the results are consistent with it being E. coli
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AspRS (Figure 2.4B). This was our first indication that Sa2591 is a functional ortholog of
Hp0100.
Sa2591 was assayed for ATPase activity using a continuous, spectrophotometric,
enzyme-coupled assay (Figure 2.5) [21]. The results show that Sa2591 hydrolyzes ATP
to ADP and Pi only in the presence of misacylated tRNAs (Figure 2.6A) and not in the
presence of correctly aminoacylated tRNAs (Figure 2.6B) when tRNAs that were
overexpressed in E. coli were used. Sa2591 ATPase activity was only slightly stimulated
in the presence of Asp-tRNAAsn when the tRNA was in vitro transcribed and therefore
lacking all post-transcriptional modifications (Figure 2.6C). These results suggest that
tRNA modifications are crucial for the ATPase activity of Sa2591 and that Sa2591 seems
to be a functional ortholog of Hp0100 under conditions that most closely recapitulate
those encountered in vivo (namely, with modified tRNA substrates).
Working with Hp0100 proved intractable and thus we chose to characterize Sa2591,
building on and completing Dr. Gayathri Silva’s work with Hp0100 [38]. The results
presented in this chapter are just the beginning of the characterization of Sa2591. Sa2591
contains a putative metal binding site and the characterization of its metal binding has
been completed and is the focus of Chapter 3. We are currently making analogous
mutations in the AANH and P-loop domain of Sa2591 as those that were inserted into
Hp0100 [38]. Analyses of these mutant variants are expected to demonstrate that the two
ATPase active sites of Sa2591 can be functionally separated, results that were never
published by Dr. Silva because of challenges working with Hp0100 in vitro. Studies to
characterize the effect of Sa2591 on the transamidation activity of GatCAB are also
currently underway and are being conducted by Udumbara Rathnayake. It is also

41
assumed that Sa2591 will increase the transamidation rates of Asp-tRNAAsn to AsntRNAAsn and Glu-tRNAGln to Gln-tRNAGln by GatCAB. Importantly, given the results
presented here, we will now also more deeply assess the impact of post-transcriptional
modifications on the different roles played by Sa2591.
Future studies should also confirm that Sa2591 is necessary to form an S. aureus
transamidosome complex similar to Hp0100’s central role in the H. pylori Asntransamidosome [34]. However, we cannot predict if the S. aureus transamidosome will
be exactly analogous to the H. pylori tRNA-independent transamidosomes because
Sa2591 is ~1/3 shorter than Hp0100 (Figure 2.3A). The absence of this C-terminal
extension could change the requirements for formation of an S. aureus transamidosome.
For example, the S. aureus transamidosome may or may not need tRNA for stable
complex formation. We cannot rule out that the extra domain of Hp0100 may be the
reason that the H. pylori Asn-transamidosome is tRNA-independent. It is interesting that
full-length orthologs of Hp0100 are only found in the e-proteobacteria and that the H. pylori
Asn-transamidosome is the only transamidosome known so far that is tRNA-independent
[24, 34]. Nevertheless, it is likely that the S. aureus transamidosome will prove to be
tRNA-independent as well. However, given the close functional similarities between
Hp0100 and Sa2591, we can be certain that Sa2591 is involved in indirect tRNA
aminoacylation in MRSA.
2.4 Materials and Methods
2.4.1 Materials
Primers and diethyl pyrocarbonate (DEPC) were purchased from Sigma-Aldrich (St.
Louis, MO). Restriction enzymes were purchased from New England Biolabs (NEB,
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Ipswich, MA). Plasmids for cloning were purified using the E.Z.N.A.® Plasmid Mini Kit II
from Omega Bio-Tek (Norcross, GA). Ethylenediaminetetraacetic acid (EDTA) is from
Fisher Scientific (Hampton, NH). Ampicillin, isopropyl b-D-thiogalactopyranoside (IPTG),
phenylmethanesulfonyl fluoride (PMSF), lysozyme, tris(hydroxymethyl) aminomethane
(tris), and boric acid were purchased from GoldBio Biotechnology, Inc., (St. Louis, MO).
All plasmid sequences were confirmed by the Sequencing Lab at the Applied Genomics
Technology Center at Wayne State University School of Medicine.
2.4.2 Cloning of Sa2591
The sa2591 gene was codon optimized for expression in E. coli and chemically
synthesized for insertion into the pUC57 vector by GenScript (GenScript Biotech Corp.,
Piscataway, NJ) with BamHI and SalI sites appended onto the 5’ and 3’ ends of the gene,
respectively. The gene was subsequently cloned into the EcoRV site of pUC57. The
sa2591 gene was then sub-cloned into the pQE80L vector using its BamHI and SalI
restrictions sites (pWNW002). This vector appends a His6 tag onto the N-terminus of the
encoded protein. A TEV protease cleavage site was inserted into the open-reading frame
between the His6 tag and the start codon to allow for removal of the His6 tag for later
studies where the tag would cause interference (pWNW003). To add the TEV protease
cleavage site, BamHI restriction endonuclease was used to digest pWNW002, where it
would cut the plasmid once between the His6 tag and the start codon of the sa2591 gene.
Calf Intestinal Alkaline Phosphatase (CIP, NEB, Ipswich, MA) was added to remove the
phosphates from the 5’- and 3’-ends of the pWNW002 DNA. The sequences of the
primers used to add the TEV protease cleavage site are: forward primer UD015:
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5’-GATCCGAAAACCTGTACTTCCAAGGCGGTACCG-3’ and reverse primer UD016: 5’GATCCGGTACCGCCTTGGAAGTACAGGTTTTCG-3’. These primers contain the
coding sequence for the TEV protease cleavage site and have complementary overhangs
to the BamHI-digested pWNW002. They were mixed together in an equal molar ratio (0.2
pmoles each). This primer mix was then added to BamHI-digest pWNW002 DNA in a
ratio of 5:1 (1 pmole primer mix:0.2 pmoles vector). A T4 DNA ligase reaction was
performed using enzyme and reaction buffer provided by NEB (Ipswich, MA). The ligation
reaction was transformed into E. coli DH5a chemically competent cells and was plated
on Luria Bertani (LB) plates supplemented with 0.5% glucose and 100 µg/mL ampicillin
to allow for selection of colonies. Plasmid was purified from colonies and the sequence
was confirmed resulting in pWNW003, which was used for expression of Sa2591.
2.4.3 Overexpression and purification of Sa2591
Sa2591 was overexpressed in E. coli DH5a by inoculating a 0.5 L culture of LB
medium supplemented with 0.5% glucose and 100 µg/mL ampicillin with a 5 mL overnight
culture grown in the same medium. The culture was incubated at 37 °C, 225 rpm, until
the optical density (OD) at 600 nm reached 0.4-0.6. Protein expression was induced with
1 mM ITPG. The culture was grown at 19 °C, 225 rpm, for 14-16 hours. Cells were
harvested by centrifugation. The cell pellet was suspended in 5 mL of lysis buffer (50 mM
NaH2PO4, pH 7.4, 1 M NaCl, 10 mM imidazole, 1 mM b-mercaptoethanol) and cells were
lysed using 2 mg/mL lysozyme. Aliquots of a saturated solution of PMSF (75 µL) were
added every 15 min to reduce proteolysis. The suspension was incubated on ice for 30
min and then sonication was performed 6 times using a Misonix Microson™ Ultrasonic
Cell Disruptor set at power level 4 for 10 seconds, with 50 second rest cycles on ice in
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between each pulse. Cell debris was removed by centrifugation at 14,000 rpm for 30 min
at 4 °C. The cleared lysate was filtered through a 0.8 um filter and then a 0.2 um filter
(Acrodisc® syringe filters with Supor® membrane, Pall Corporation, Port Washington,
NY) before purification on a HiTrap Chelating High Performance (HP) affinity column (GE
Healthcare Life Sciences, Pittsburg, PA). His6-Sa2591 was purified essentially according
to the manufacturer’s protocol. TEV protease was added to the eluent in a ratio of 1 mg
TEV to ~5 mg Sa2591. The cleavage reaction was diluted to 15 mL using dialysis buffer
A (50 mM NaH2PO4, pH 7.4, 300 mM NaCl, 0.5 mM EDTA, 10 mM b-mercaptoethanol)
and placed inside dialysis tubing (6-8 kDa MWCO, Spectrum Labs, Irving, TX). The
reaction was dialyzed in 2 L dialysis buffer A at 4 °C overnight to remove the His6 tag.
The dialysis buffer was exchanged to 2 L dialysis buffer B (dialysis buffer A with 1 mM bmercaptoethanol) and dialyzed for 1-2 hours. The His6-tagged TEV protease was
removed by passing the reaction through a HiTrap Chelating HP affinity column. The flow
through containing Sa2591 was concentrated using an Amicon 10 kDa MWCO tube (EMD
Millipore, Burlington, MA). The protein concentration was calculated by UV-Vis
spectroscopy at 280 nm, using Beer’s law with an extinction coefficient of 27,850 cm-1 M1

(determined by the ExPASy ProtParam tool within the Proteomics server [74]). Sa2591

was stored in 50% glycerol at -20 °C and used for assays within ~1 week of purification.

45
2.4.4 Overexpression and purification of S. aureus ND-GluRS and ND-AspRS
The S. aureus gltX (ND-GluRS) gene was codon optimized for expression in E. coli
and chemically synthesized into the pUC57 vector by GenScript (GenScript Biotech
Corp., Piscataway, NJ). BamHI and KpnI sites were engineered onto the 5’ and 3’ ends
of the gene, respectively, and the gene was cloned into the EcoRV site of pUC57. The
gltX gene was then sub-cloned into the pQE80L vector using its BamHI and KpnI
restrictions sites (pWNW009). This vector appends a 6-Histidine (His6) tag onto the Nterminus of the encoded protein. ND-GluRS was overexpressed in E. coli DH5a by
inoculating a 1 L culture of LB medium supplemented with 0.5% glucose and 100 µg/mL
ampicillin with a 10 mL overnight culture grown in the same medium. The culture was
incubated at 37 °C, 225 rpm, until the OD at 600 nm reached 0.8-1.0. Protein expression
was induced with 1 mM ITPG. The culture was grown at 19 °C, 225 rpm for 4 hours. Cells
were harvested by centrifugation. The cell pellet was lysed following the protocol
described above for Sa2591 in the same lysis buffer except with the addition of 300 mM
NaCl. The cleared lysate was added to a polyprep column that contained ~2 mL of HighDensity Cobalt Agarose Beads (GoldBio Biotechnology, Inc., St. Louis, MO) and the
lysate was incubated with the resin by rotating at 4 °C for 1 hour. His6-ND-GluRS was
purified essentially according to the manufacturer’s protocol. The eluent was added to
dialysis tubing (6-8 kDa MWCO, Spectrum Labs, Irving, TX) and dialyzed against 2 L
dialysis buffer (50 mM NaH2PO4, pH 7.4, 300 mM NaCl) at 4 °C for 1-2 hours and then
against fresh dialysis buffer overnight. ND-GluRS was concentrated using an Amicon 30
kDa MWCO tube (EMD Millipore, Burlington, MA). The protein concentration was
calculated by UV-Vis spectroscopy at 280 nm using an extinction coefficient of 69,790

46
cm-1 M-1 [74]. ND-GluRS was stored in 50% glycerol at -20 °C and used within ~1-2
months of purification.
The S. aureus ND-AspRS plasmid was kindly provided by Kelly Sheppard. The protein
was overexpressed in E. coli BL21(DE3) RIL and purified as previously described [16].
ND-AspRS was concentrated using an Amicon 30 kDa MWCO tube (EMD Millipore,
Burlington, MA). The protein concentration was calculated by UV-Vis spectroscopy at 280
nm using the extinction coefficient of 48,820 cm-1 M-1 [74]. ND-AspRS was stored in 50%
glycerol at -20 °C and used within ~1-2 months of purification.
2.4.5 In vivo expression of S. aureus tRNAAsn, tRNAAsp, tRNAGln, and tRNAGlu
S. aureus tRNAs were overexpressed in the E. coli strain MV1184, purified, folded
and quantified by aminoacylation assay as previously described [23]. This approach
provides tRNA that is highly enriched in the overexpressed isoacceptor but also contains
total E. coli tRNA.
2.4.6 In vitro transcription of S. aureus tRNAAsn and tRNAAsp
The S. aureus tRNAAsp plasmid was kindly provided by Kelly Sheppard, and tRNAAsn
plasmid was chemically synthesized into the pUC57 vector by GenScript (GenScript
Biotech Corp., Piscataway, NJ). The 2 tRNA plasmids contain a T7 RNA polymerase
promoter sequence and a BstNI site at the 5’ and 3’ ends of the tRNA DNA sequence,
respectively. This sequence allows for run-off transcription of the BstNI-digested plasmid
DNA that results in unmodified tRNA with the correct 5’ and 3’ termini, specifically in tRNA
that begin with a 5’-guanine (G) base [75]. However, for the tRNAAsn plasmid, a
hammerhead ribozyme sequence was added between the T7 RNA polymerase promoter
sequence and the start of the tRNA DNA sequence because its tRNA sequence starts
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with a uracil (U) base [76]. This modification was performed because T7 RNA polymerase
leaves the last G base of its promoter sequence as the starting base of the RNA transcript
[76]. After transcription, a hammerhead ribozyme reaction was performed so that the
resulting tRNAAsn transcript begins with its native 5’-U base. S. aureus tRNAAsp starts with
a 5’-G base, so the hammerhead ribozyme was not needed.
All buffers used for plasmid purifications, BstNI digestions, transcriptions, and
hammerhead ribozyme reactions were made in DEPC-treated water unless buffers were
provided by the relevant companies. Transcription reactions were performed as
previously described [75], except 5 µM T7 RNA polymerase was used and reactions were
performed at 30 °C for 2 hours. Transcription of tRNAAsn was performed using 30 mM
MgCl2, whereas only 1 mM MgCl2 was used for transcription of tRNAAsp. The
hammerhead ribozyme reaction for tRNAAsn transcripts was performed as previously
described [76], expect reactions were incubated for 2 hours. For both tRNA transcripts
after phenol/chloroform extraction and isopropanol precipitations, the tRNAs were purified
using a 9 M urea, 8% acrylamide (Bio-Rad Laboratories, Inc., Hercules, CA) mini gel in
TBE running buffer (89 mM tris, 89 mM boric acid, 2 mM EDTA, pH 8.0) at 300 volts for
30 minutes. The tRNA transcript band was excised from the gel and pushed through a 3
mL syringe to crush the gel into pieces. The crushed gel pieces and crush and soak buffer
(0.5 M ammonium acetate, 1 mM EDTA, pH 5.2) were added to a polyprep column and
incubated at 37 °C overnight while rotating. The buffer suspension was eluted from the
polyprep column and the eluent was isopropanol precipitated for 1 hour at -20 °C. The
tRNA transcripts were centrifuged at 10,000 x g for 20 min and the pellet was dried and
suspended in water.

48
2.4.7 Size exclusion chromatography suggests that E. coli AspRS co-purifies with
Sa2591
Immediately following the purification of Sa2591 from TEV protease by nickel affinity
chromatography, Sa2591 was concentrated to ~2 mL using an Amicon 10 kDa MWCO
centrifuge tube (EMD Millipore, Burlington, MA). This was filtered using a 0.2 um syringe
filter and injected onto a FCV-20AH2 Shimadzu High Pressure Switching Valve unit
(Shimadzu, Kyoto, Kyoto Prefecture, Japan) connected with a 2 mL loop. The column
was packed with Sephacryl™ S-300 High Resolution size exclusion chromatography
resin (GE Healthcare Bio-Sciences, Uppsala, Sweden). The column was connected to a
LC-20AD Shimadzu Liquid Chromatography solvent delivery unit. Size exclusion
chromatography was performed at 4 °C using Shimadzu LC Solutions software and the
settings were as follows: Pump B was set at 0% (100% Pump A), 0.5 mL/min flowrate,
2000 µL injection volume, 360 min data acquisition, isocratic flow, and maximum pressure
was set at 150 psi. SEC buffer was used for Pump A (50 mM NaH2PO4, pH 7.4, 300 mM
NaCl). Fractions (5 mL) were collected beginning at 120 min, and were collected until 300
minutes. Fractions were analyzed by 12% SDS-PAGE.
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2.4.8 Aminoacylation assays of tRNAs
All tRNAs was refolded in the presence of 2 mM MgCl2 and aminoacylation assays
were performed as previously described [13]. For aminoacylation assays with tRNAAsp to
test if E. coli AspRS was co-purifying with Sa2591, 6.5 µg of total protein from the fractions
collected from SEC were used to initiate the assay. For aminoacylation assays to
misacylate S. aureus tRNAAsn and tRNAGln or to correctly aminoacylate S. aureus tRNAAsp
and tRNAGlu, 1 µM S. aureus ND-AspRS and ND-GluRS were used, respectively. Stocks
of Asp-tRNAAsn, Glu-tRNAGln, Asp-tRNAAsp, and Glu-tRNAGlu (100 µM) were prepared in
parallel to assays that contained radiolabeled amino acids.
2.4.9 Enzyme-coupled ATPase assay for ADP detection
ATPase assays were performed as previously described [21]. This assay monitors
ATP hydrolysis to ADP + Pi specifically by coupling ADP production to the oxidation of
NADH to NAD+. The decrease in NADH can be monitored over time at 340 nm and is
directly correlated to the production of ADP. Assays were done using 10 µM misacylated
or correctly aminoacylated tRNA. All assays were conducted in triplicate from different
enzyme purifications (biological replicates). Assays were performed in a Beckman Coulter
DU800 spectrophotometer, recording absorbance readings at 340 nm every 2 seconds
for a total of 5.5 minutes. Assays were initiated with the addition of 200 nM Sa2591 only
after the absorbance at 340 nm had stabilized. Absorbance was converted to NADH
concentration using 6,220 M-1 cm-1 as the extinction coefficient (Sigma-Aldrich, St. Louis,
MO) [77]. Data was averaged and plotted as NADH concentration versus time with
standard deviation for each time point represented as error bars on the plot.
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CHAPTER 3: QUEH, A MISACYLATED-TRNA-DEPENDENT ATPASE AND
PROBABLE EPOXYQUEUOSINE REDUCTASE, IS A METALLOPROTIEN
3.1 Introduction

Our lab discovered that Hp0100 and its orthologs are involved in indirect tRNA
aminoacylation. Hp0100 is required for tRNA-independent Asn-transamidosome complex
formation in H. pylori and it accelerates the transamidation of Asp-tRNAAsn to Asn-tRNAAsn
by GatCAB [34]. In Chapter 2, a truncated version of Hp0100 from S. aureus, Sa2591,
was characterized and results suggest that it is a functional ortholog of Hp0100. These
proteins, all members of the DUF208 superfamily, have two distinct ATPase active sites,
an AANH-like domain and a P-loop, that are activated by misacylated tRNAs. We have
unpublished data that suggest that ATP hydrolysis is connected to their ability to activate
GatCAB. While full-length orthologs of Hp0100 are unique to the e-proteobacteria,
truncated versions, comprising approximately 2/3 of the primary sequence are found in
many different bacteria (Figure 3.1). Figure 3.1 shows alignments of the primary
sequence of DUF208 from 7 different bacterial species. Remarkably, comparative
genomics identified the DUF208 protein family as epoxyqueuosine reductases,
responsible for catalyzing the final step in queuosine biosynthesis [48].
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Figure 3.1. Sequence alignments of DUF 208 proteins from different bacterial
species. The sequence alignments from 7 different bacteria are shown. Hp, H. pylori;
Tm, T. maritima; De, D. ethenogenes; Bp, B. pertussis; Sp, S. pyogenes; Se, S.
epidermidis; and Sa, S. aureus. Rigorously conserved residues are labeled with an
asterisk; highly conserved residues are marked with a colon; and loosely conserved
residues are marked with a period.
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Queuosine (Q) is a post-transcriptionally modified guanosine base found at the first
position in the anticodons of tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr [49]. The last three
steps of queuosine biosynthesis occur on the tRNA and utilize 3 enzymes: tRNA-guanine
tranglycosylase (TGT), QueA, and QueG (Figure 1.8) [50-52]. Several bacteria have TGT
and QueA, and contain queuosine in there tRNA, but lack QueG. This observation led de
Crécy-Lagard and coworkers to identify the DUF208 family of proteins as non-orthologous
replacements to QueG [48]. Proteins from this group, including Hp0100 and Sa2591,
were able to restore queuosine biosynthesis in a ∆QueG E. coli strain by
complementation. These authors proposed naming the DUF208 proteins QueH [48].
Consequently, from here on, Sa2591 will be called QueH.
QueG contains a redox chain of two [4Fe-4S] iron-sulfur clusters and uses cobalamin
to reduce epoxyqueuosine to queuosine [53, 54]. However, de Crécy-Lagard and coworkers did not find any cobalamin associated with QueH [48]. In our model structure of
S. aureus QueH (Sa2591), there are several, clustered, conserved cysteine residues,
including a CXXC motif in the P-loop ATPase domain (Figure 3.2) [47]. This chapter
focuses on our analysis of the metal-binding capacity of S. aureus QueH. Using different
spectroscopy techniques, we have demonstrated that S. aureus QueH binds at least two
Fe(II) atoms, although these irons are not in an Fe-S cluster. We hypothesized that S.
aureus QueH uses its Fe2+-binding sites to reduce epoxyqueuosine to queuosine and we
conducted a number of assays in an attempt to observe this activity. QueH has proven to
be a complex protein that is involved in many different aspects of tRNA biology.

Figure 3.1
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3.2 Results
3.2.1 QueH has an Fe(II) binding site
The model structure of QueH shows a putative metal binding site with 5 conserved
cysteines clustered together (Figure 3.2) [47]. To gain preliminary evidence of metal
binding, several different monovalent, divalent, and trivalent metal ions were
spectroscopically analyzed with QueH by performing UV-Vis wavelength scans from 250
– 700 nm. In each experiment, QueH and the relevant metal solution were scanned alone
and together. Difference spectra, subtracting the metal alone and QueH alone spectra
from the combined spectrum, were used to visualize potential metal-binding effects.
Figure 3.3 shows this series of spectra for 4 different metals (panels A-D). Fe(II) was the

54

Figure 3.2

only metal that had any effect, (Figure 3.3A, inset); the shift in the spectrum around 360
nm suggests Fe(II) binding to QueH.
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3.2.2 QueH binds two Fe(II) ions with low micromolar Kd values
To further investigate interactions between QueH and Fe(II), we collaborated with Dr.
Timothy Stemmler and Brianne Lewis at the Wayne State University School of
Pharmaceutical Sciences. We utilized an Fe(II) competition binding assay that relies on
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the metal chelator, mag-fura-2 [78]. Mag-fura-2 binds Fe(II) in a 1:1 complex with a Kd of
2.0 µM (Figure 3.4) [78]. It has a characteristic UV absorbance at 366 nm in its apo state,
which shifts to 325 nm upon Fe(II) binding. This competition assay was used with QueH
to determine the stoichiometry of Fe(II) binding and to estimate the Kd of this interaction
(Figure 3.4). Figure 3.4B shows results of a representative assay with QueH and magfura-2 in a 1:1 molar ratio; Fe(II) was titrated in from 0 to ~40 µM. A progressive decrease
in absorbance at 366 nm with a concomitant increase in absorbance at 325 nm was
observed, indicating Fe(II) binding to QueH. Several competition assays were conducted,
varying the ratio of QueH:mag-fura-2.

Figure 3.3
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Using the program DynaFit (BioKin Ltd., Watertown, MS), the absorption decay at 366
nm was used to determine stoichiometry of Fe(II) binding to QueH and to estimate Kd.
The data from these assays were fit to models of a 1:1, 1:2, and 1:3 QueH:Fe(II) binding
ratio (equations 1 – 3, respectively).
QeuH-Fe(II)

Kd1

QueH-Fe(II)-Fe(II)

QueH + Fe(II)
Kd2

QueH-Fe(II)-Fe(II)-Fe(II)

QueH + Fe(II) + Fe(II)
Kd3

QueH + Fe(II) + Fe(II) + Fe(II)

(eq. 1)
(eq. 2)
(eq. 3)

In all cases, results were best fit to a 1:2 binding model, eq. 2 (Figure 3.5). The
estimated Kd values for each binding event are 4.5 ± 1.0 µM and 11.2 ± 3.7 µM. Figure
3.5 shows the representative fits for a 1:2 QueH:Fe(II) binding model that was generated
from absorption decay at 366 nm from data collected from competition assays with 1:2
QueH:mag-fura-2 (blue line), 1:1 QueH:mag-fura-2 (black line), 2:1 QueH:mag-fura-2
(green line). These results show that all 3 ratios of QueH:mag-fura-2 best fit a 1:2
QueH:Fe(II) binding model.

Figure 3.4
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3.2.3 X-Ray absorption spectroscopy confirms QueH binds Fe(II)
represent the data fits used to obtain Kd values for both Fe(II) binding events (4.5 µM
and
11.2 µM).
X-Ray
absorption spectroscopy (XAS) data were collected at the Stanford
Synchrotron Radiation Lightsource at the SLAC National Accelerator Laboratory [79].
Duplicate samples of QueH were loaded with 2 equivalents of Fe(II) under anaerobic
conditions for full Fe-XAS analysis. The X-Ray absorption near edge structure (XANES)
spectra are shown in Figure 3.6. Based on the edge energy, each QueH sample contains
a high spin ferrous species. The inset in Figure 3.6 shows the pre-edge feature between
7110 – 7115 eV for both samples. This region is consistent with a 1s-3d electronic
transition. The pre-edge peak areas for both QueH samples are 2.68 and 2.54,
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respectively (Figure 3.6 inset and Table 3.1), which suggest a symmetric, six coordinate
system. Controls were done with Fe(II)SO4 and Fe(III)SO4 (not shown), which had peak
inflections of 7124.1 and 7127.3 eV, respectively (Table 3.1). The first inflection points of

Figure 3.5

the two samples of QueH are 7123.9 and 7124.0 eV, respectively (Figure 3.6 and Table
3.1). These inflection points in the XANES, compared to the standards, confirms that
QueH preferentially binds Fe(II) and not Fe(III).

Figure 3.6. XANES spectra of QueH-Fe(II). Duplicate samples of QueH loaded with 2
equivalents of Fe(II) are shown in black and blue. The first inflection points of the two
Figure 3.5. X-Ray Absorption Near Edge Structure (XANES) of QueH-Fe(II).
samples are 7123.9 eV and 7124.0 eV, which correspond to the inflection point of an
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pre-edge features between 7110 – 7115 eV for both samples. XAS was conducted at
the Stanford Synchrotron Radiation Lightsource and data was analyzed by Brianne
Lewis.
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Table 3.1. Fe-XANES analysis of pre-edge area and edge first-inflection points for
QueH.
Pre-Edge Area Peak-First Inflection
(dimensionless)
Energy (eV)
QueH Sample 1
2.68
7123.9
QueH Sample 2
2.54
7124.0
1
Fe(II)SO4 control
5.18
7124.1
Fe(III)SO4 control
3.62
7127.3
1
Published pre-edge area value for Fe(II) standard [80].
2
Published pre-edge area value for Fe(III) standard [81].
The extended X-Ray absorption fine structure (EXAFS) results for QueH are shown
in Figure 3.7. Both samples of QueH bound to Fe(II) show similar iron ligation. Figure
3.7 shows the raw, unfiltered Fe-EXAFS data (black line) and the best-fit simulations
(green line) with a resolution of 0.13 Å. The best fit for both QueH samples and the
statistical analysis are described in Table 3.2. QueH contains 3 Fe-O/N vectors with a
bond length of 2.08 Å and an independent Fe-O/N vector at 2.19 Å. Long range Fe-C
vectors were also observed with bond lengths of 3.17 Å and 3.75 Å for the two Fe(II) ions,
respectively. These XAS data for QueH are consistent with a six-coordinate ferrous iron
center dominated by O/N ligands with long range carbon scattering. In the model of QeuH
there are 5 conserved cysteines that are clustered together, which is where we expected
the two Fe(II) ions to bind; however, sulfur coordination was not observed in the EXAFS.

Figure 3.6
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Figure 3.7. EXAFS analysis of QueH-Fe(II). Raw k3-weighted EXAFS data and phase
shifted Fourier Transform (FT) are shown. A. EXAFS of QueH-Fe(II) sample 1 and B. FT
of QueH-Fe(II) sample 1. C. EXAFS of QueH-Fe(II) sample 2 and D. FT of QueH-Fe(II)
sample 2. The raw unfiltered data is shown in black and best-fit simulations are shown in
Figure
3.6.XAS
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green.
was conducted
the StanfordFine
Synchrotron
Radiation
Lightsource
and data
3
Rawwas
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phase
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Transform
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are
shown.
analyzed by Brianne Lewis.

A. EXAFS of QueH-Fe(II) sample 1 and B. FT of QueH-Fe(II) sample 1. C. EXAFS of
QueH-Fe(II) sample 2 and D. FT of QueH-Fe(II) sample 2. The raw unfiltered data is
shown in black and best-fit simulations are shown in green. XAS was conducted at
the Stanford Synchrotron Radiation Lightsource and data was analyzed by Brianne
Lewis.
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Table 3.2. Summary of Fe EXAFS simulations for QueH

QueH
Sample 1
QueH
Sample 2

Nearest-Neighbor Ligand
Long-Range Ligand Environment1
Environment1
2
Atom
R (Å)3 C.N.4 s2 5 Atom2
R (Å)3
C.N.4
F’ 6
s2 5
O/N
2.08
3.0 5.17
C
3.17
2.0
4.57 0.39
O/N
O/N

2.19
2.05

2.0
3.0

5.19
3.82

C
C

3.75
3.16

2.0
3.0

2.36
4.86

0.38

O/N
2.19
3.0 4.31
C
3.59
2.0
4.97
Independent metal-ligand scattering environment
2
Scattering atoms: N (nitrogen), O (oxygen), C (carbon)
3
Average metal-ligand bond length (+/-) 0.13 Å
4
Average metal-ligand coordination number (+/-) 1.0
5
Average Debye-Waller factor (Å x 103)
6
Number of degrees of freedom weighted mean square deviation between data and fit
1

3.2.4 QueH secondary structure does not change upon Fe(II) binding
Circular Dichroism (CD) spectra were collected for QueH with and without Fe(II) bound
(Figure 3.8). The CD spectrum of Apo-QueH (Figure 3.8, black line) represents the first
experimental structural analysis for QueH, since we only have a model structure for this
enzyme generated by I-TASSER [47]. Values for the different secondary structures of
QueH were determined using the COTIN method from 5 databases [82]. The final
analysis parameters are shown in Table 3.3. QueH was determined to be 16.8% a-helix,
28.6% b-sheet, 23.1% other secondary structure, and 31.6% disordered (Table 3.3).
These values differ from those that were calculated from the model structure of QueH,
suggesting that the model is inaccurate (Table 3.3). No significant structural changes
were observed when 2 equivalents of Fe(II) were loaded onto QueH (Holo-QueH).

Figure 3.7
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Figure 3.8. Circular dichroism of Apo-QueH and Holo-QueH. l = Apo-QeuH; l =
Holo-QeuH (QueH loaded with 2 equivalents of Fe(II)). CD spectroscopy was conducted
in an anaerobic chamber in Dr. Stemmler’s lab with Brianne Lewis.
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Apo-QueH
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31.6 ± 1.1
Holo-QueH
16.2 ± 5.8 28.7 ± 5.2
23.1 ± 0.2
32.1 ± 0.4
Model of QueH1
42.1
3.3
ND
ND
1
Percentages for the model of QueH were calculated using the STRIDE
secondary structure assignment program [83]. ND = not determined.

Fit
0.06
0.07
ND
server, a

3.2.5 Epoxyqueuosine reductase activity of QueH
We hypothesized that QueH uses its Fe(II)-binding sites to reduce epoxyqueuosine to
queuosine. Twenty-eight different conditions were tested for epoxyqueuosine reductase
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activity in QueH. All assays were done in an anaerobic chamber and used tRNA purified
from a DQueG E. coli strain. The conditions tested included varying the concentration of
QueH, adding more than 2 equivalents of Fe(II), adding ATP, MgCl2, and EDTA. Figure
3.9A shows the LC-MS traces for epoxyqueuosine and queuosine controls. Figure 3.9B
shows the LC-MS traces for assays done with QueH and QueH loaded with 2 equivalents
of Fe(II), only two of the conditions that were tested. In these LC-MS traces, only peaks
corresponding to epoxyqueuosine were observed indicating that we were unable to
recapitulate de Crécy-Lagard and co-workers’ results in vitro [48].

Figure 3.8
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3.3 Discussion
Recently, through comparative genomics, de Crécy-Lagard and coworkers identified
the DUF208 protein family, which includes Sa2591 and Hp0100, as epoxyqueuosine
reductases and named them QueH [48]. Queuosine is a hypermodified guanosine base
found in 4 different tRNAs: tRNAAsn, tRNAAsp, tRNAHis, and tRNATyr [49]. In some
organisms, like E. coli, the last step of queuosine biosynthesis is achieved by a
cobalamin-dependent epoxyqueuosine reductase called QueG (Figure 1.8) [52].
However, there are many microorganisms that lack QueG, but still contain TGT, QueA,
and queuosine in their tRNAs. This observation was used to guide the search for QueH
[48]. QueH is not a homolog of QueG and it does not contain cobalamin [48]. Our lab had
discovered Hp0100 (now H. pylori QueH) for its involvement in indirect tRNA
aminoacylation before the report of QueH and Chapter 2 of this thesis focused on
characterizing the ATPase activity of Sa2519 (now S. aureus QueH). We have
unpublished data that show that these proteins contain two different ATPase active sites:
an AANH-like domain that is activated by Glu-tRNAGln and P-loop domain that is activated
by Asp-tRNAAsn [38].
In the model structure of S. aureus QueH (Sa2591), there are 5 conserved cysteine
residues clustered together that make up a putative metal binding site (Figure 3.2) [47].
Notably, there is a CXXC sequence, a known metal-kkkkkkbinding motif, in the P-loop
ATPase active site of S. aureus QueH (Sa2591) (Figure 3.2). It cannot be a coincidence
that QueH contains a putative metal biding site that could provide a path for
epoxyqueuosine reduction and that this site is close to the P-loop ATPase active site,
which is activated by Asp-tRNAAsn, a tRNA that contains queuosine. In this chapter, metal
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binding by QueH was characterized through different spectroscopic techniques and we
assayed S. aureus QueH for epoxyqueuosine reductase activity.
We first tested several different metals for binding to S. aureus QueH, including;
monovalent, divalent, and trivalent metal ions, via UV-visible spectroscopy wavelength
scans. The only metal that gave a shift in its spectrum upon mixing with the protein
compared to metal alone was Fe(II) (Figure 3.3A). This observation was the first
evidence that S. aureus QueH is an Fe(II) binding metalloprotein.
We then started a collaboration with Dr. Timothy Stemmler to further characterize the
Fe(II) binding of S. aureus QueH. Dr. Stemmler has optimized an Fe(II) competition
binding assay that utilizes the metal chelator mag-fura-2 [78]. This assay was used to
calculate the stoichiometry of Fe(II) binding to S. aureus QueH and the Kd values for the
binding event(s). When Fe(II) is titrated into a solution containing both S. aureus QueH
and mag-fura-2, QueH competes with mag-fura-2 for Fe(II) binding, which causes a decay
in mag-fura-2 absorption at 366 nm (Figure 3.4). This absorbance decrease was used to
fit different models of Fe(II) binding to S. aureus QueH. Data from 3 competition binding
assays, wherein the ratio of QueH:mag-fura-2 was varied, were fit to 3 different Fe(II)
binding models (eq. 1 – 3). For each competition assay the data best fit a 1:2 QueH:Fe(II)
binding model (Figure 3.5). The estimated Kd of both Fe(II) binding events are 4.5 ± 1.0
µM and 11.2 ± 3.7 µM, respectively.
Once the stoichiometry of binding had been determined, we obtained XAS data for S.
aureus QueH bound to two Fe(II) ions to provide more insight into the local metal
environment. There are two regions of XAS, XANES and EXAFS. The XANES region
gives information about the metals oxidation state and geometry and the EXAFS region
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gives insight specifically into metal-ligand interactions. The XANES data confirmed that
the oxidation state of the iron bound to S. aureus QueH is Fe(II) and not Fe(III) (Figure
3.6 and Table 3.1). The pre-edge peak areas in the two XANES spectra suggest that the
geometry of the Fe(II) is a symmetric six-coordinate system with an octahedral geometry
(Figure 3.6 and Table 3.1). The EXAFS showed that the ferrous iron center is dominated
by O/N vectors with long range carbon scattering (Figure 3.7 and Table 3.2). From the
model structure of S. aureus QueH, it was expected that the two Fe(II) ions would be
coordinated by sulfurs from the conserved cysteine residues near the P-loop ATPase
domain (Figure 3.2), possibly in an Fe-S cluster. The EXAFS spectra did not show sulfur
coordination (Figure 3.7), inconsistent with this model.
CD spectroscopy was also conducted with S. aureus QueH in its apo and holo state
(Figure 3.8 and Table 3.3). From the model structure of S. aureus QueH, it was
calculated that the protein is 42.1% a-helixes and 3.3% b-sheet. However, from the CD
fitting parameters, it was calculated that S. aureus QueH is 16.8% a-helixes and 28.6%
b-sheet (Table 3.3). CD spectroscopy was also performed with S. aureus QueH loaded
with 2 equivalents of Fe(II) and there was no change in the secondary structure upon
Fe(II) binding (Figure 3.8 and Table 3.3).
From these experiments, we can conclude that S. aureus QueH is a metalloprotein
that preferentially binds 2 Fe(II) ions using O/N ligands. We have hypothesized that QueH
would use its 2 Fe(II) ions to reduce epoxyqueuosine to queuosine. de Crécy-Lagard and
coworkers showed this activity in vivo by complementing different orthologs of QueH into
a DQueG E. coli strain [48]. We wanted to recapitulate this activity in vitro and show that
this activity is dependent on Fe(II) bound to QueH. For these experiments we began a
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collaboration with Dr. Valérie de Crécy-Lagard and Dr. Rémi Zallot. Using tRNA that was
purified from a DQueG E. coli strain, several different assay conditions were tested for S.
aureus QueH epoxyqueuosine reductase activity, however, we were unable to see any
evidence of queuosine formation (Figure 3.9).
After obtaining the results from XAS and the negative epoxyqueuosine reductase
assays, we resubmitted the sequence of S. aureus QueH to I-TASSER [47]. This time,
two of the protein structures that I-TASSER used for model building were 2-thiouridine
synthetase (TtuA) from two different organisms [45, 46]. Like QueH, TtuA is a tRNA
modifying enzyme that contains a CXXC metal binding motif next to a P-loop ATPase
domain. Recently, a new crystal structure of TtuA revealed a [4Fe-4S] iron-sulfur cluster
that is coordinated by the two cysteines in the CXXC motif and another cysteine in the
protein (Figure 3.10) [46]. The structural similarities between our QueH model and the
TtuA crystal structure suggest an explanation for why XAS didn’t show any sulfur
coordination and why the epoxyqueuosine reductase assays were unsuccessful. Our
XAS data show the two Fe(II) ions that are bound to QueH coordinated to O/N ligands,
leaving room for an incompletely formed Fe-S cluster. In fact, Tanaka and coworkers had
to reconstitute the [4Fe-4S] cluster in TtuA [46]. Thus, it seems probable that S. aureus
QueH contains a mature [4Fe-4S] cluster in vivo that is involved in epoxyqueuosine
reduction, explaining the ability of this enzyme to complement a ∆QueG E. coli strain [48].
Presumably, this activity was missing in our in vitro assays because we did not install this
critical catalytic feature. Future experiments should focus on reconstituting the iron-sulfur
cluster in S. aureus QueH and conducting CD and XAS experiments to see how the
spectra change. Also, the likelihood is high that epoxyqueuosine reductase assays will
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prove to be more informative when reexamined with S. aureus QueH with an intact ironsulfur cluster. There is always the possibility that the iron-sulfur cluster alone will not result
in epoxyqueuosine reductase activity if it follows a mechanism similar to that of TtuA,
which needs a sulfur donor from TtuB (Figure 1.9) [45, 46].

Figure 3.9

Figure 3.10. Structural similarities between QueH and TtuA. A. Model of QueH
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Given the similarities between our QueH model and TtuA, it is possible to propose a
mechanism for QueH for future studies (Figure 3.11). In this mechanism, an activated
sulfur atom will attack one of the carbon atoms in the epoxide ring of epoxyqueuosine,
which will open the ring and allow for nucleophilic attack by the oxygen at the a-phosphate
of ATP, activating this oxygen. The activated sulfur atom (R1 in Figure 3.11) could be
attached to several different sources. For example, one of the Fe(II) ions that is attached
to QueH, to the probable iron-sulfur cluster that is in QueH, a persulfide, or possibly a
protein partner similar to TtuB delivering an activated sulfur to TtuA. In the intermediate
step, a second activated sulfur atom would attack the first sulfur atom creating a disulfide
bond, allowing for the reduction of the carbon-carbon bond and AMP as the leaving group.
This would produce the desired product, queuosine. The second activated sulfur atom
(R2 in Figure 3.11) could be attached to any of the options listed above for R1 however,
it is most likely from a free cysteine residue in the active site of QueH. From Figure 3.1,
there are 5 cysteine residues clustered together near the P-loop ATPase domain: C129,
C132, C209, C211, and C213. From the alignment of our QueH model and TtuA (Figure
3.10), the 3 cysteine residues that would be involved in coordinating the iron-sulfur cluster
would be C129, C132, and C213. This arrangement would allow for either C209 or C211
to act as the second activated sulfur in the reduction of epoxyqueuosine to queuosine.

Figure 3.10
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3.4 Materials and Methods
3.4.1 Materials
Hepes and ATP were purchased from GoldBio Biotechnology, Inc., (St. Louis, MO).
Mag-fura-2, tris(2-carboxyethyl)phosphine (TCEP), EDTA, NaCl, and MgCl2 were
purchased

from

ThermoFisher

Scientific

(Hampton,

NH).

Fe(NH4)2(SO4)2,

b-
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mercaptoethanol, and all metal compounds were purchased from Sigma Aldrich (St.
Louis, MO).
3.4.2 Overexpression and purification of S. aureus QueH (Sa2591)
S. aureus QueH (Sa2591) was overexpressed and purified as described in Chapter 2.
After The His6-tagged TEV protease was removed from QueH by passing the reaction
through a HiTrap Chelating HP affinity column, the flow through containing QueH was
dialyzed against 1 L dialysis buffer C (20 mM Hepes, pH 7.5, 300 mM NaCl, 5 mM bmercaptoethanol) twice for 1 hour each time. S. aureus QueH was concentrated using an
Amicon 10 kDa MWCO tube (EMD Millipore, Burlington, MA) and protein concentration
was calculated as described in Chapter 2.
3.4.3 Assessing metal-binding to S. aureus QueH using UV-Vis spectroscopy
UV-Vis wavelength scans were obtained on a Beckman DU800 spectrophotometer
from 250 – 700 nm under aerobic conditions. Metal solutions (2 mM) were made fresh in
degassed water prior to each experiment. Scans of 0.5 mM metal in 100 mM Hepes
buffer, pH 7.4 were done with and without 20 µM QueH. The metal solution was mixed
with QueH by pipetting up and down and UV-Vis scans were immediately taken at room
temperature to minimize oxidation. The different metal solutions that were tested are as
follows: FeSO4, FeCl2, FeCl3, CuCl, CuCl2, ZnSO4, NiSO4, MgCl2, MnCl2, and MnSO4.
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3.4.4 Fe(II) competition binding assay
The Fe(II) competition binding assays were conducted in Dr. Timothy Stemmler’s lab
located in the Pharmacy School at Wayne State University with Brianne Lewis. The
competition assays were performed as previously described [78] except for the following
changes. Samples were prepared in 20 mM HEPES, pH 7.5, 300 mM NaCl and 5 mM
TCEP. All reagents/buffers except for the protein were Ar (g) purged and equilibrated
overnight in a wet anaerobic chamber. After purification of S. aureus QueH and dialysis
into buffer C as described above, the protein was equilibrated in a wet anaerobic chamber
for 1 hour/mL of sample. The absorbance at 366 nm was corrected for dilution and used
to calculate binding parameters using DYNAFIT. Binding data were fit using a non-linear
least squares analysis script to calculated the Fe(II) stoichiometry and Kd of the binding
event(s). Each reaction was simulated using one, two, and three-site binding models.
3.4.5 X-Ray absorption spectroscopy (XAS)
Full Fe XAS data were collected by Dr. Timothy Stemmler at the Stanford Synchrotron
Radiation Lightsource (SSRL) on beamline 9-3. Duplicate samples of S. aureus QueH
were loaded with 2 equivalents of Fe(II) (1.2 mM Fe(NH4)2(SO4)2) in a buffer of 20 mM
Hepes, pH 7.5, 300 mM NaCl, 5 mM TCEP. The samples were stored in liquid nitrogen
prior to beam exposure. Approximately four scans were collected on each sample, which
were averaged together to obtain the final analysis. This analysis was performed by
Brianne Lewis.
3.4.6 Circular dichroism spectroscopy of S. aureus QueH
CD spectra of 50 µM apo-QueH and holo-QueH (QueH loaded with 2 equivalents of
Fe(II)) in 20 mM Hepes, pH 7.5, 300 mM NaCl were prepared in a Coy wet anaerobic
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chamber. Spectra were collected using a 0.01 cm anaerobic quartz cuvette on a Jasco
1500 spectrophotometer with a Peltier VT unit set at room temperature. Ten scans were
taken for each sample with triplicate QueH samples purified from 3 different colonies
(biological replicates). A baseline was subtracted to eliminate buffer signal. Data were
analyzed using the Jasco CD Pro analysis software and simulated using the CONTIN
method (with the SP29, SP37, SP43, SMP50 and SMP56 reference sets) [82]. Values
obtained from simulations using each database were averaged to obtain final analysis
parameters.
3.4.7 Total tRNA purification
Transfer RNA (tRNA) was purified from a DqueG E. coli strain that was provided by Dr.
Rémi Zallot [48]. Purification of the tRNA was performed as previously described [23].
3.4.8 Epoxyqueuosine reduction assay
The tRNA was refolded by heating to 75 °C and cooling to 65 °C, at which point MgCl2
was added to a final concentration of 2 mM and the tRNA was slowly cooled to room
temperature. The refolded tRNA, S. aureus QueH, and all other reagents were
equilibrated in an anaerobic chamber located in Dr. Stemmler’s lab for 1 – 2 hours prior
to use. All assays were performed in this chamber. S. aureus QueH was loaded with 2
equivalents of Fe(II) using a fresh solution of Fe(NH4)2(SO4)2. All reactions contained 200
µg tRNA, 1 µM S. aureus QueH with or without Fe(II) and 4 mM MgCl2 and were
performed in a buffer containing 20 mM Hepes, pH 7.5, 300 mM NaCl, 5 mM bmarcaptoethanol. Several different reaction conditions were tested which included:
adding 2 mM ATP, 0.2 mM EDTA, 5 µM Fe(NH4)2(SO4)2, 10 µM Fe(NH4)2(SO4)2, using
100 nM S. aureus QueH (instead of 1 µM), and adding 1 µL of lysate from DQueG E. coli
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in varying combinations Reactions were mixed in the anaerobic chamber and initiated
with S. aureus QueH at which point the reaction tubes were sealed and removed from the
chamber and incubated at 37 °C for 1 hour. The reactions were quenched with 5 mM
EDTA and put into a -80 °C freezer. The tRNA was enzymatically digested to individual
nucleosides as previously described [48]. Liquid chromatography-mass spectrometry and
analysis was performed by Dr. Rémi Zallot at the Carl R. Woese Institute for Genomic
Biology at University of Illinois at Urbana-Champaign.
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CHAPTER 4: TRANSFER RNA-INDUCED PRODUCTION OF ADP BY MANY
AMINOACYL-TRNA SYNTHETASES
The majority of this chapter has been submitted for publication and is under review.
4.1 Introduction
The aminoacyl-tRNA synthetases (aaRSs) are central to protein biosynthesis because
each of these enzymes catalyzes the attachment of a single amino acid to its cognate
tRNA(s), usually with high substrate specificity (Figure 1.1A). Their products, the
aminoacyl-tRNAs (aa-tRNAs), are subsequently used in protein biosynthesis by the
ribosome (Figure 1.1B). All aaRSs consume ATP en route to their aa-tRNA products via
two reactions (Figure 1.2). First, the cognate amino acid (specific to a given aaRS) is
condensed with ATP to produce an aminoacyl-adenylate (aa-AMP), releasing PPi
(reaction 1). Next, the activated amino acid is transferred to its cognate tRNA, to produce
the aa-tRNA and AMP (reaction 2). This dependence on ATP and production of AMP
was elucidated for the yeast methionyl-tRNA synthetase (MetRS) and rat liver leucyltRNA synthetase (LeuRS) in the 1950’s [84, 85]. We now know that these reactions are
evolutionarily conserved across all three domains of life and all known aaRSs [3-5].
aaRS + aa + ATP à aaRS•aa-AMP + PPi

(Rxn 1)

aaRS•aa-AMP + tRNAaa à aaRS + aa-tRNA + AMP

(Rxn 2)

Despite sharing the same reaction pathways, the aaRS are divided into two classes
(Class I and Class II), based on the structure of their active sites. The aaRSs can also be
further divided into subclasses based on their structures and various functional
idiosyncrasies (Table 1.2) [4, 5].
We are unaware of published or anecdotal evidence that aaRSs can produce ADP
instead of AMP. We recently discovered this activity serendipitously when using H. pylori
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GluRS2 (a misacylating glutamyl-tRNA synthetase used in indirect tRNA aminoacylation
[9, 14]) and its substrates glutamate and tRNAGln to produce AMP as a positive control
for a TLC assay, when the unexpected production of ADP was observed.
To determine whether this activity was unique to GluRS2 or represented an activity
intrinsic to aaRSs, we screened 25 different aaRSs from three different bacterial species,
including all 20 E. coli aaRSs, for their ability to produce ADP from ATP in the presence
of tRNA. Remarkably, we’ve identified a number of aaRSs that are capable of robustly
generating ADP in the presence of tRNA. Possible functional roles for this activity are
discussed.
4.2 Results
4.2.1 H. pylori GluRS2 produces ADP from ATP
In a paper published by our group [23], we investigated the phosphorylation of
aminocylated-tRNAs by GatCAB, the amidotransferase that uses glutamine as an
ammonia donor to transamidate misacylated tRNAs (Asp-tRNAAsn and Glu-tRNAGln) to
the correctly aminoacylated tRNAs (Asn-tRNAAsn and Gln-tRNAGln, respectively) [23].
GatCAB uses ATP to activate its two misacylated tRNA substrates by phosphorylating
the side chain of the non-cognate amino acid while it is attached to the tRNA [23]. The
side product of this phosphorylation reaction is ADP. In an effort to more sensitively
observe initial phosphorylation rates for this reaction, we set out to develop a radiolabeled
thin layer chromatography (TLC) assay using a-32P-ATP as the GatCAB substrate with
Glu-tRNAGln. Radiolabelled TLC controls were needed for a-32P-ADP and a-32P-AMP.
Protein kinase A and kemptide [86] were used for the a-32P-ADP control and an
aminoacylation assay using H. pylori GluRS2 (a misacylating glutamyl-tRNA synthetase
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Figure 4.1

that produces Glu-tRNAGln [9, 14]) with H. pylori tRNAGln and glutamate was used for the
a-32P-AMP control. Unexpectedly, phosphorimaging of the TLC revealed the presence of
a-32P-ADP as a product of H. pylori GluRS2 (Figure 4.1). To our knowledge, this is the
first time that any aaRS has been shown to produce ADP instead of AMP, the expected
product.

AMP
ADP

ATP

1

2

Figure 4.1. H. pylori GluRS2 produces ADP from ATP. a-32P-ATP and a-32P-ADP were
separated by TLC in 1 M LiCl2. Lane 1, Protein kinase A and kemptide plus a-32P-ATP as
an ADP positive control. Lane 2, H. pylori GluRS2 with Glu and H. pylori tRNAGln plus a32
P-ATP.
H. pylori GluRS2 is distinct among the aaRSs because it only misacylates tRNAGln
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Figure 4.2
80

ADP production (Figure 4.2). These results confirm that ADP is produced by both GluRS1

A

and GluRS2.
se

B.

Hp GluRS1

Hp GluRS1 + Hp tRNAGlu1

240

Hp GluRS1 +
Hp tRNAGlu1

220
200

ADP/lane (pmoles)

Pr

o te

in

Ki

na

A.

ADP

180
160
140
120

ATP

100

1 2 3 4 5 6 7 8 9 101112 1314151617 1819

Time (min)

Time (min)

80
0

2

4

6

8

10

Time (min)

Figure 4.2. H. pylori GluRS1 produces ADP in a tRNA- and time-dependent manner.
A. a-32P-ATP and a-32P-ADP were separated by TLC in 1 M LiCl2. Lane 1, Protein kinase
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To more thoroughly and broadly examine this activity, we turned to a facile enzymecoupled assay for ADP detection. This continuous, spectrophotometric assay provides
initial rates for ATP hydrolysis to ADP and Pi [21]. ADP production is coupled to NADH
oxidation via pyruvate kinase and lactate dehydrogenase with phosphoenolpyruvate and
NADH as substrates, respectively. A decrease in absorbance at 340 nm (due to NADH
oxidation) directly correlates to ADP production (Figure 2.5A). Importantly, oxidation of
NADH does not occur in the presence of either ATP or AMP (Figure 2.5B), demonstrating
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that this assay is specific for ADP. We used this assay to more quantitatively characterize
ADP production by GluRS1 and GluRS2 and to determine if other aaRSs involved in
indirect tRNA aminoacylation also have the capacity to produce ADP.
The aaRSs involved in indirect tRNA aminoacylation from H. pylori and M. smegmatis
were analyzed for their rates of ADP production with their specific tRNA substrates (Table
4.1). Hp GluRS1 was examined with tRNAGlu1 as its representative tRNA substrate.
(GluRS1 also aminoacylates the Hp tRNAGlu2 isoacceptor [9, 14].) Hp GluRS2 is
specifically a misacylating aaRS that solely produces Glu-tRNAGln; consequently, it was
examined with tRNAGln specifically [9, 14]. H. pylori ND-AspRS is a non-discriminating
aspartyl-tRNA synthetase that aminoacylates both tRNAAsp and tRNAAsn with aspartate to
make the correctly aminoacylated product Asp-tRNAAsp and the misacylated product AsptRNAAsn, respectively [13]. ND-AspRS was tested with both H. pylori tRNAAsp and tRNAAsn.
We also examined the two non-discriminating aaRSs from M. smegamits (ND-GluRS and
ND-AspRS) specifically with their non-cognate tRNA substrates, tRNAGln and tRNAAsn,
respectfully.
Four different assays were performed with each enzyme/tRNA pair, in triplicate from
biological replicates: (1) aaRS alone; (2) aaRS with tRNA; (3) aaRS with cognate amino
acid and tRNA; and, (4) aaRS with cognate amino acid. Table 4.1 lists the observed rates
of ADP production for these five aaRSs with respect to basal activity and the impact of
tRNA on ADP production (Assays 1-3). (Rates of ADP production for assays with aaRS
plus cognate amino acid were uniformly slow and demonstrated that the addition of amino
acid had little effect on ADP production (Assay 4, Table 4.2).)
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All five enzymes (100 nM) were capable of slowly producing ADP from ATP in the
absence of tRNA, with rates ranging from 0.62 µM/min (Ms ND-GluRS) to 1.13 µM/min (Hp
GluRS2 and ND-AspRS). These rates increased by 1.9- to 27.3-fold in the presence of
specific tRNAs. The highest increases were observed with the two M. smegmatis aaRSs,
Ms-ND-GluRS (27.3-fold) and ND-AspRS (5.7-fold), with their non-cognate tRNAGln and
tRNAAsn substrates, respectively. Interestingly, tRNAAsp and tRNAAsn similarly, and only

Figure 4.3

weakly, stimulated ADP production by Hp ND-AspRS (1.9- and 2.3-fold for final rates of
2.15 and 1.57 µM/min, respectively) (Figure 4.3). Surprisingly, the addition of amino acid
under conditions expected
favor tRNA aminoacylation has no significant effect on rates
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of ADP production (Table 4.1).
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Figure 4.3. Hp tRNAAsp and Hp tRNAAsn weakly stimulate ADP production by Hp NDAspRS. ATPase assays with H. pylori ND-AspRS with A. H. pylori tRNAAsp and B. H.
pylori tRNAAsn are shown. All assays were conducted with overexpressed tRNA. Error
bars represent standard deviation from triplicate measurements (biological replicates).
See Table 4.1 above and Table 4.2 for rates. l = Hp ND-AspRS alone; n = Hp NDAspRS + Hp tRNAAsp/Asn
; u = Hp ND-AspRS
+ Asp + Hp tRNAAsp/Asn; ▲ = Hp ND-AspRS
Asp
Asn
and Hp tRNA
weakly stimulate ADP production by Hp
+ Figure
Asp. 4.3. Hp tRNA
ND-AspRS. ATPase assays with H. pylori ND-AspRS with A. H. pylori tRNAAsp and
B. H. pylori tRNAAsn are shown. All assays were conducted with overexpressed tRNA.
Error bars represent standard deviation from triplicate measurements (biological
replicates). See Table 4.1 above and Table 4.2 for rates. ● = Hp ND-AspRS alone; ■
= Hp ND-AspRS + Hp tRNAAsp/Asn; ◆ = Hp ND-AspRS + Asp + Hp tRNAAsp/Asn; ▲ =
Hp ND-AspRS + Asp.
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Table 4.1. Rate of ATP hydrolysis to ADP and Pi for aaRSs involved in indirect tRNA
aminoacylation in H. pylori and M. smegmatis.
Rate of ADP Production (µM/min)2
tRNA
aaRS +
aaRS
tRNA1
aaRS +
aaRS
4
impact
tRNA &
tRNA
alone
aa3
Hp ND-AspRS
tRNAAsp 2.15 ± 0.40 1.87 ± 0.12 1.13 ± 0.07
1.9
Hp ND-AspRS
tRNAAsn 1.57 ± 0.11 1.88 ± 0.30 0.68 ± 0.16
2.3
Glu1
Hp GluRS1
tRNA
2.19 ± 0.38 2.42 ± 0.52 0.83 ± 0.16
2.6
Hp GluRS2
tRNAGln 3.01 ± 0.31 2.81 ± 0.55 1.13 ± 0.13
2.7
Asn
Ms ND-AspRS
tRNA
4.41 ± 0.19 4.13 ± 0.22 0.78 ± 0.54
5.7
Gln
Ms ND-GluRS
tRNA
16.9 ± 1.6
15.8 ± 1.3 0.62 ± 0.84
27.3
1
Each tRNA was overexpressed in E. coli and quantified with the appropriate aaRS. The
final tRNA stock solutions are contaminated with total E. coli tRNA (tRNA, 10 µM).
2
Errors represent standard deviations from biological replicates of each enzyme.
3
Each enzyme was assayed in the presence of its cognate amino acid (aa, 100 µM).
4
The impact of tRNA on the rate of ADP production was calculated by dividing the rate
observed with tRNA by that observed in the absence of tRNA.
Table 4.2. ADP production by misacylating aaRSs in the absence of tRNA
Rate of ADP
Production (µM/min) aa impact2
+ aa1 aaRS alone
Hp ND-AspRS
1.41
1.13 ± 0.13
1.25
Hp ND-AspRS
0.99
0.68 ± 0.16
1.46
Hp GluRS1
1.22
0.83 ± 0.16
1.47
Hp GluRS2
0.78
1.13 ± 0.13
0.69
Ms ND-AspRS
1.62
0.8 ± 0.5
2.08
Ms ND-GluRS
1.52
0.6 ± 0.8
2.45
1
Cognate amino acid (100 µM) was used with each enzyme.
2
aa impact was determined by dividing the +aa rate by the rate observed in the absence
of aa.
aaRS

4.2.2 Many E. coli aaRSs produce ADP in the presence of tRNA
To assess if ADP production is an activity ubiquitous across the aaRS, we next
screened all 20 E. coli aaRSs for ADP production using the spectrophotometric assay
described above and the same series of four assays per enzyme. A 20-fold range of rates
were observed across this series (Table 4.3). Figure 4.4 shows comparative rates for the
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enzyme with the slowest quantifiable, basal rate in the presence of tRNA (HisRS), an
average enzyme (TyrRS), and the fastest enzyme (LeuRS). The complete data set of
rates from triplicate measurements are provided in Table 4.3 listed in order from fastest
to slowest rate measured in the presence of total E. coli. Results from the ATPase assays
for all 25 aaRSs that were screened in this study can be found at the end of this chapter
(Figure 4.8A-Z).
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Figure 4.4. The E. coli aaRSs exhibit a 20-fold range of rates for ADP production
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assay
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E. coli HisRS; B. E. coli TyrRS; and, C. E. coli LeuRS. All assays were conducted
from triplicate measurements. See Table 4.3 and 4.4 for rates. l = aaRS alone; n =
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Table 4.3. Rates of ATP hydrolysis to ADP and Pi for the 20 E. coli aaRSs.

LeuRS

Rate of ADP Production (µM/min)1
tRNA
aaRS +
aaRS +
aaRS alone impact4
tRNA2
tRNA & aa3
36.3 ± 0.9
35.0 ± 0.9
0.60 ± 0.10
60.5

ValRS

23.0 ± 2.0

25.4 ± 1.4

1.00 ± 0.14

23.0

PheRS

19.5 ± 0.9

19.2 ± 0.6

0.52 ± 0.12

37.5

AlaRS

17.7 ± 1.6

17.5 ± 1.1

0.36 ± 0.01

49.1

GlyRS

17.5 ± 2.4

17.8 ± 2.2

0.42 ± 0.08

41.7

ThrRS

10.6 ± 0.4

12.5 ± 1.6

1.57 ± 0.07

6.8

CysRS

9.7 ± 2.1

11.1 ± 0.6

1.59 ± 0.28

6.1

ProRS

9.3 ± 4.7

9.3 ± 3.8

0.47 ± 0.75

19.8

AspRS

9.1 ± 0.3

7.7 ± 2.1

0.25 ± 0.12

36.0

GlnRS

7.7 ± 2.5

8.9 ± 2.3

1.87 ± 0.14

4.1

AsnRS

7.1 ± 1.5

7.1 ± 1.5

1.66 ± 0.08

4.3

ArgRS

6.6 ± 1.3

5.8 ± 2.5

1.15 ± 0.09

5.5

TyrRS

4.6 ± 1.7

4.2 ± 1.5

0.14 ± 0.02

32.9

SerRS

4.2 ± 1.5

3.5 ± 1.3

0.20 ± 0.06

21

IleRS

3.1 ± 0.6

2.7 ±0.7

1.10 ± 0.17

2.8

TrpRS

2.9 ± 1.6

2.3 ± 1.1

0.21 ± 0.09

13.8

MetRS

2.12 ± 0.26

2.43 ± 0.86

1.25 ± 0.02

1.7

GluRS

1.91 ± 0.28

1.29 ± 0.57

0.88 ± 0.16

2.2

HisRS

1.85 ± 0.16

1.39 ± 0.24

1.35 ± 0.20

1.4

aaRS

LysRS
1.80 ± 0.19 1.68 ± 0.24
0.00 ± 0.07
ND
Errors represent standard deviations from biological replicates of each enzyme.
2
Total E. coli tRNA was used with an estimated concentration of 10 µM for each
isoacceptor.
3
Each enzyme was assayed in the presence of its cognate amino acid (100 µM).
4
The impact of tRNA on the rate of ADP production was calculated by dividing the rate
observed with tRNA by that observed in the absence of tRNA.
1
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Table 4.4. ADP production by E. coli aaRSs in the absence of tRNA
aaRS

Rate of ADP Production
(µM/min)
1

aa impact2

aaRS alone
+ aa
LeuRS
0.62
1.03
0.60 ± 0.10
AlaRS
0.18
0.50
0.36 ± 0.01
CysRS
1.26
1.59 ± 0.28
0.79
AspRS
0.10
0.25 ± 0.12
0.40
GluRS
1.27
1.44
0.88 ± 0.16
PheRS
0.53
1.02
0.52 ± 0.12
GlyRS
0.35
0.83
0.42 ± 0.08
HisRS
1.15
0.85
1.35 ± 0.20
IleRS
1.13
1.03
1.10 ± 0.17
LysRS
0.06
ND
0.00 ± 0.07
MetRS
1.36
1.09
1.25 ± 0.02
AsnRS
1.66
1.66 ± 0.08
1.00
ProRS
1.24
0.47 ± 0.75
2.64
GlnRS
1.73
0.93
1.87 ± 0.14
ArgRS
1.23
1.07
1.15 ± 0.09
SerRS
0.14
0.70
0.20 ± 0.06
ThrRS
1.76
1.12
1.57 ± 0.07
ValRS
0.72
0.72
1.00 ± 0.14
TrpRS
0.19
0.90
0.21 ± 0.09
TyrRS
0.14
0.14 ± 0.02
1.00
1
Cognate amino acid (100 µM) was used with each enzyme.
2
aa impact was determined by dividing the +aa rate by the rate observed in the absence
of aa.
E. coli LysRS was the slowest enzyme overall with a tRNA-dependent rate of 1.80
µM/min in the presence of tRNA and an essentially undetectable rate in the absence of
tRNA that approximated zero. E. coli LeuRS showed the highest rate overall in the
presence of tRNA. (36.3 µM/min), but not in the absence of tRNA (0.60 µM/min),
amounting to a 60.5-fold increase in ADP production in the presence of tRNA. GlnRS
showed the fastest rate of ADP production in the absence of tRNA with a rate of 1.87
µM/min; however, the addition of tRNA in this case had only a 4.1-fold effect, increasing
the rate of ADP production to 7.7 µM/min. These observed rates show that the 20 E. coli
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aaRSs exhibit a 20-fold range in rates of ATP hydrolysis to ADP and Pi. Clearly, ADP
production by the discriminating E. coli aaRSs are also dependent on deacylated tRNA.
Further, they demonstrate that this activity is highly varied across the aaRSs.
4.2.3 Rates of ADP production for the 20 E. coli aaRSs show a pattern among the
subclasses
The E. coli aaRSs show a wide range of rates for ADP production when assayed with
total E. coli tRNA, ranging from 1.8 – 36.3 µM/min (Table 4.3). These rates were arranged
by aaRS subclass into a bar graph (Figure 4.5). The aaRSs with the most robust rates of
ADP production cluster into subclasses Ia, IIa, and IIc.

Figure 4.5
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4.2.4 ADPreplicates,
production
species
AspRS from three different organisms, E. coli, H. pylori, and M. smegmatis, were
compared for their rates of ADP production using the enzyme-coupled ATPase assays
(Figure 4.6). It is worth noting that E. coli AspRS is a discriminating aaRS (D-AspRS) and
was assayed with total E. coli tRNA, while the H. pylori and M. smegmatis AspRSs are
non-discriminating (ND-AspRS) and were assayed with their species-specific tRNAAsn. E.
coli AspRS demonstrates the fastest rate at 9.1 µM/min (Table 4.3 and Figure 4.6),
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compared to rates of 1.6 to 4.4 µM/min for Hp ND-AspRS and Ms ND-AspRS, respectively

Figure 4.6

(Table 4.1 and Figure 4.6).
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Figure 4.6. Comparison of ADP production rates for AspRS from different species.
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We also conducted a similar comparison across four different GluRS species from
three organisms (Figure 4.7). H. pylori utilizes two different GluRS orthologs, one that
glutamylates tRNAGlu1 and tRNAGlu2 (GluRS1), and another that specifically misacylates
tRNAGln with glutamate (GluRS2) [9, 14]. M. smegmatis has one ND-GluRS (a nondiscriminating aaRS) that aminoacylates tRNAGlu and tRNAGln with glutamate, and E. coli
has a D-GluRS (a discriminating aaRS) that only glutamylates tRNAGlu isoacceptors. A
comparison of these four enzymes with different tRNA substrates reveals that the Ms NDGluRS is the fastest ADP producer across this series with a rate of 16.9 µM/min (Table
4.1 and Figure 4.7). The three other enzymes (Hp GluRS1, Hp GluRS2, and Ec D-GluRS)
all show similar, slow rates of ADP production between 1.91 and 3.0 µM/min. These
comparisons suggest that, while ADP production is conserved across species, the rates
of this activity are not.

Figure 4.7
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4.2.5 Examination of enzyme components for autophosphorylation
To determine whether the aaRSs were catalyzing an auto-phosphorylation reaction, in
the presence of deacylated tRNA, g-32P-ATP (2.5 Ci/mol), and tRNA were co-incubated
over 30 minutes and analyzed by phosphorimaging. No evidence of auto-phosphorylation
was obtained (data not shown).
4.3 Discussion
It is well established that aaRSs catalyze the ATP-dependent esterification of an amino
acid to its cognate tRNA, simultaneously producing AMP and PPi [3-5]. We are unaware
of any evidence that aaRSs can produce ADP instead of AMP. However, we
serendipitously discovered this activity when using H. pylori GluRS2 with glutamate and
tRNAGln to produce AMP as a positive control on a TLC (Figure 4.1). Building on this
discovery, twenty-five aaRSs from three different organisms were screened for ADP
production activity in the present work. This activity seems to be ubiquitous among all
aaRSs, albeit to varying extents. The data presented herein allow for a number of
interesting comparisons to be made.
The E. coli aaRSs show rates of ADP production in the presence of tRNA that span a
20-fold range (from 1.8-36.3 µM/min, Table 4.3), with the rates of the aaRSs from H.
pylori and M. smegmatis falling on the lower end of this scale (with rates from 1.6-16.9
µM/min, Table 4.1). The rates of the E. coli enzymes have been grouped by enzyme
subclass in Figure 4.5. Notably, the aaRSs with the most robust activities fall in
subclasses Ia and IIa, with the exception of PheRS, which is in subclass IIc. It has been
proposed that the aaRSs evolved in pairs across the two classes [57, 87, 88]. The
observation that ADP production rates also group by subclass suggests that this activity
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may have emerged prior to fixation of the genetic code when the aaRSs still shared close
connections across classes.
Many aaRSs have editing activities that promote accurate tRNA aminoacylation in the
presence of near-cognate amino acids. LeuRS and ValRS are class I aaRSs with wellcharacterized editing activities and they also exhibit the highest rates of ADP production
(36.3 and 23.0 µM/min, respectively), suggesting a possible connection between editing
and ATP hydrolysis to ADP. This hypothesis is belied by the fact that IleRS, another Class
I aaRS that edits, exhibits one of the lowest rates of ADP production (3.1 µM/min). A
similar disconnect is observed between Class II aaRS that edit and their ATPase
activities. For example, GlyRS has a high rate of ATPase activity but no known editing
activity. These comparisons suggest that ADP production evolved separately and
independently from editing activity; nevertheless, it will be important to reexamine these
rates of ADP production in future work to determine if the addition of non-cognate amino
acids has any effect.
We can also draw conclusions from a comparison of ATPase activities across species.
When comparing AspRS from 3 different species, it is interesting that the rate of ADP
production by E. coli D-AspRS is faster than the rate for either H. pylori or M. smegmatis
ND-AspRS (Figure 4.6). In contrast, M. smegmatis ND-GluRS is faster than either H.
pylori GluRS1 or GluRS2 or E. coli D-GluRS (Figure 4.7). These comparisons argue that
ADP production is not connected to the relaxed tRNA specificity of non-discriminating
aaRSs. It is worth noting that in the assays with the H. pylori and M. smegmatis aaRSs,
species-specific tRNAs were used and in the assays with E. coli aaRSs, total E. coli tRNA
was used.
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In general, the observed basal rates for each enzyme and those measured in the
presence of amino acid alone proved to be fairly low and uninteresting. What is
unexpected is the fact that the addition of amino acid and tRNA did not statistically impact
the observed rates of ADP production in nearly any case. These conditions would be
expected to favor tRNA aminoacylation exclusively and yet ATP hydrolysis to ADP
continued undisrupted. While we don’t yet understand this observation, it may offer a clue
to why aaRSs hydrolyze ATP to ADP. We hypothesize that this activity may represent a
stress response in vivo (discussed further below). Perhaps, some specific condition of
our assays inadvertently recapitulates the conditions needed in vivo to trigger ADP
production. There is the possibility that this activity may not be relevant in vivo however,
with the varying rates amongst the different aaRSs it suggests that there is some in vivo
relevance for this ADP production.
In an effort to understand why this activity exists, we considered possible roles that
might be played by each of the two products: Pi and ADP. First, we examined a selection
of E. coli aaRSs (AsnRS, GlnRS, IleRS, and MetRS) for evidence of autophosphorylation.
Exhaustive attempts to observe enzyme phosphorylation through the use of radiolabeled
ATP were unsuccessful however, leading us to conclude that autophosphorylation is not
occurring.
The well-established stringent pathway senses amino acid starvation using
deacylated tRNA as a signaling molecule [89]. Because deacylated tRNAs also trigger
ADP production by the aaRSs, we considered the possibility that elevations in ADP
concentrations could offer another signal for amino acid starvation. However, this
scenario seems unlikely, because different aaRSs all produce ADP indiscriminately.
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Instead, we hypothesize that ADP production by the aaRSs could contribute to persister
cell formation in the presence of deacylated tRNAs. Bacterial persisters are a
subpopulation of microbial cells that are in a dormant state, which causes them to be
tolerant to bactericidal antibiotics [90]. Several reports have demonstrated that a drop in
intracellular ATP concentration can trigger persister cell formation [91-93]. Perhaps, when
bacteria are under stress, the aaRSs bind to deacylated tRNAs to stimulate ATP
hydrolysis to ADP and Pi, lowering intracellular ATP and inducing a persister state. Such
a scenario offers a tantalizing possible explanation for this unexpected, yet ubiquitous,
aaRS activity.
4.4 Materials and Methods
4.4.1 Materials
Antibiotics, isopropyl b-D-thiogalactopyranoside (IPTG), phenylmethanesulfonyl
fluoride (PMSF), Hepes, ATP, dithiothreitol (DTT) and lysozyme were purchased from
GoldBio Biotechnology, Inc., (St. Louis, MO). Nicotinamide adenine dinucleotide (NADH),
phosphoenolpyruvate (PEP), pyruvate kinase (PK), L-lactate dehydrogenase (LDH), and
NaH2PO4 were purchased from Sigma Aldrich (St. Louis, MO). Polyethylenimine (PEI)
cellulose thin-layer chromatography (TLC) plates were purchase from EMD Millipore
(Burlington, MA). Yeast extract, peptone, NaCl, glycerol, sodium dodecyl sulfate (SDS),
and imidazole were purchased from Fisher Scientific (Hampton, NH). a-32P-ATP and g32

P-ATP were purchased from American Radiolabeled Chemicals, Inc. (St. Louis, MO).

4.4.2 Protein overexpression and purification
Unless otherwise stated, all aaRS were overexpressed in E. coli Bl21(DE3) RIL by
inoculating a 100 mL culture of Luria-Bertani (LB) medium supplemented with 0.5%
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glucose and the appropriate antibiotic (Table 4.5) with a 1 mL overnight culture grown in
the same medium. Each culture was incubated at 37 °C with shaking at 225 rpm until the
optical density (OD) at 600 nm reached 0.4-0.6 (unless otherwise stated). Protein
expression was induced with 1 mM IPTG. Each culture was grown at 37 °C for 4 hours
with shaking at 225 rpm. Cells were harvested by centrifugation. All non-discriminating
aaRSs were grown until the OD at 600 nm reached 0.8-1.0, then protein expression was
induced with 1 mM IPTG. Each culture was harvested after 1 hour of overexpression at
37 °C.
Each cell pellet was suspended in 400 µL equilibration buffer (50 mM NaH2PO4, pH
7.4, 300 mM NaCl, 10 mM imidazole) and lysozyme was added to a final concentration
of 2 mg/mL. The suspension was incubated on ice for 30 min. An aliquot of a saturated
solution of PMSF (7.5 µL) was added every 15 min to reduce proteolysis. Sonication was
performed 6 times using a Misonix Microson™ Ultrasonic Cell Disruptor set at power level
4 for 10 seconds, with 50 second rest cycles on ice between each pulse. The lysate was
clarified by centrifugation at 14,000 rpm for 30 min at 4 °C. Proteins were purified following
the manufacture’s protocol for HisPur Ni-NTA spin columns (ThermoScientific, Rockford,
IL) with the following modifications: the equilibration buffer contained 50 mM NaH2PO4
and the wash buffer contained 20 mM imidazole. Each aaRS was dialyzed against and
concentrated in dialysis buffer (50 mM NaH2PO4, pH 7.4, 300 mM NaCl) using a 0.5 mL
Amicon 30 KDa molecular weight cut-off filter (EMD Millipore, Burlington, MA). Proteins
were judged to be >95% pure by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). Each enzyme was stored in 50% glycerol and used within
a week of purification. Each protein concentration was determined by UV-Vis
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spectroscopy at 280 nm, using Beer’s law and an extinction coefficient that was
determined using the ExPASy ProtParam tool within the Proteomics server [74]. Each
aaRS was grown and purified in triplicate from three different colonies (biological
replicates).
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Table 4.5. Summary of plasmids used in this study.

1

aaRS1
Ec AlaRS
Ec ArgRS
Ec AsnRS
Ec AspRS
Ec CysRS
Ec GlnRS
Ec GluRS
Ec GlyRS
Ec HisRS
Ec IleRS
Ec LeuRS
Ec LysRS
Ec MetRS
Ec PheRS
Ec ProRS
Ec SerRS
Ec ThrRS
Ec TrpRS
Ec TyrRS
Ec ValRS
Hp ND-AspRS
Hp GluRS1
Hp GluRS2
Ms ND-AspRS

Vector
pQE30
pET16b
Unknown
pET21a
pET21a
pSJW1
pET21a
pET21a
pET21a
pKS21
pET21a
pET21a
pET28a
pQE30
pET21a
pET21a
pQE30
pET21a
pET21a
pET21a
pQE80L
pQE80L
pQE80L
pET28a

Antibiotic resistance marker
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Kanamycin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Kanamycin

Ms ND-GluRS

pET28a

Kanamycin

tRNA1
Hp tRNAAsp
Hp tRNAAsn
Hp tRNAGlu1
Hp tRNAGln
Ms tRNAAsn

Vector
pES300
pES300
pES300
pES300
pES300

Antibiotic resistance marker
Ampicillin
Ampicillin
Ampicillin
Ampicillin
Ampicillin

Ms tRNAGln

pES300

Ampicillin

Reference
[94]
[94]
Unknown
[94]
[94]
[95]
[94]
[94]
[94]
[96]
[94]
[94]
[97]
[94]
[94]
[94]
[94]
[94]
[94]
[94]
[13]
[9]
[9]
Kindly provided by
Babak Javid
Kindly provided by
Babak Javid
Reference
[13]
[13]
[9]
[9]
Kindly provided by
Babak Javid
Kindly provided by
Babak Javid

Vectors were kindly provided by Professors Rebecca Alexander, Babak Javid, John
Perona, and Takuya Ueda.
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4.4.3 tRNA overexpression and purification
M. smegmatis tRNAAsn and tRNAGln, H. pylori tRNAAsn, tRNAAsp, tRNAGln, and tRNAGlu1
were overexpressed in the E. coli strain MV1184, purified, folded and quantified by
aminoacylation assay as previously described [23]. This approach provides tRNA that is
highly enriched in the overexpressed isoacceptor but also contains total E. coli tRNA. For
assays with E. coli aaRSs, total E. coli tRNA was isolated from 1 L E. coli MV1184 in LB
medium supplemented with 0.5% glucose. The culture was incubated at 37 °C with
shaking at 225 rpm until the optical density (OD) at 600 nm reached 0.4-0.6 at which point
the cells were harvested by centrifugation (mid-log phase). Total E. coli tRNA was isolated
from this cell pellet as described [23]. The concentration of the total tRNA was calculated
by UV-Vis spectroscopy at 260 nm assuming 1 OD = 1.6 µM. This number was divided
by 20 to approximate the concentration for each tRNA isoacceptor.
4.4.4 Thin-layer chromatography
ATPase assays for H. pylori GluRS1 and GluRS2 were performed using a-32P-ATP
and the hydrolysis products were separated by TLC. These assays were performed at 37
°C in reaction buffer containing 40 mM Hepes, pH 7.5, 4 mM ATP, 2.5 Ci/mol a-32P-ATP,
and 8 mM MgCl2. In assays that contained tRNA, 10 µM species-specific isoacceptor
tRNA was used and in assays that contained amino acid, 100 µM cognate amino acid
was used. Each assays was initiated with 1 µM aaRS and 5 µL aliquots were taken at 0,
1, 2, 3, 4, 5, 6, 8, and 10 min and quenched into 5 µL of ice-cold 2x quench buffer (20
mM NH2OH, 50 mM EDTA, 50 mM Hepes, pH 7.5). Spots (2 µL) were made 1 cm apart
on PEI cellulose TLC plates and the TLC was run in 1 M LiCl2. Once the buffer was 1 cm
from the top of the TLC, the plate was dried and developed on a Molecular Dynamics
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Storage Phosphor screen overnight and imaged on a Typhoon FLA 9500 Biomolecular
Imager (GE Healthcare Life Sciences, Pittsburgh, PA, USA). Quantification was
conducted using ImageQuant software (GE Healthcare Life Sciences).
4.4.5 Enzyme assays to quantify ADP production
ATPase assays were performed as previously described [21]. This assays monitors
ATP hydrolysis to ADP + Pi specifically by coupling ADP production to the oxidation of
NADH to NAD+. The decrease in NADH can be monitored over time at 340 nm and is
directly correlated to the production of ADP (Figure 2.5). Four different assays were
conducted for each aaRS: (1) 100 nM aaRS alone; (2) 100 nM aaRS and ~10 µM cognate,
species-specific tRNA; (3) 100 nM aaRS, 0.1 mM cognate amino acid, and 10 µM tRNA;
and, (4) 100 nM aaRS and 0.1 mM cognate amino acid. All assays were conducted in
triplicate from different enzyme purifications, except for assay 4 (enzyme + amino acid),
which was only measured once per aaRS. Assays were performed in a Beckman Coulter
DU800 spectrophotometer, recording absorbance readings at 340 nm every 2 or 5
seconds for a total of 5.5 minutes. Assays were initiated with the addition of the aaRS
only after the absorbance at 340 nm had stabilized. Data were averaged and plotted as
absorbance versus time. The y-intercept of the assay with aaRS only (assay 1) was used
to calculate the initial NADH concentration with 6,220 M-1 cm-1 as the extinction coefficient
[77]. This concentration was then used to normalize the starting NADH concentration for
all other assays conducted with the same aaRS. This normalization was necessary
because the tRNA has a background absorbance at 340 nm, presumably due to the
presence of a post-transcriptional modification.
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4.4.6 Autophosphorylation analysis
Assays using g-32P-ATP were conducted to investigate if the aaRSs ATPase activity
caused autophosphorylation of the protein. These assays were performed at 37 °C in
reaction buffer containing 40 mM Hepes, pH 7.5, 4 mM ATP, 2.5 Ci/mol g-32P-ATP, and
8 mM MgCl2. In assays that contained tRNA, ~10 µM cognate total E. coli tRNA was used.
Each assay was initiated with 1 µM aaRS (E. coli AsnRS, GlnRS, IleRS, and MetRS) and
incubated at 37 °C for 30 minutes, at which time a 20 µL aliquot was quenched into 20
µL of ice-cold 2x quench buffer (20 mM NH2OH, 50 mM EDTA, 50 mM Hepes, pH 7.5).
SDS-PAGE loading buffer (50 mM Tris-HCl, pH 6.8, 100 mM DTT, 2% SDS, 0.1%
bromophenol blue, 10% glycerol) was added to the sample and boiled for 10 minutes
before running on a 12% SDS-PAGE. After the gel was done running, it was soaked in
3% glycerol, 40% methanol, 10% acetic acid for 1 hour before drying on a BioRad Model
583 gel dryer at 70 °C for 1 – 2 hours. The gel was developed on a Molecular Dynamics
Storage Phosphor screen overnight and imaged on a Typhoon FLA 9500 Biomolecular
Imager (GE Healthcare Life Sciences).
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Figure 4.8. ATPase assays for all 25 aaRSs that were screened as part of this work.
A. – Z. Figures are listed in the order they are presented in Table 4.1 and 4.2. l = aaRS
alone; n = aaRS + tRNA; u = aaRS + aa + tRNA; ▲ = aaRS + aa.
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E. Ms ND-AspRS ATPase
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F.

Ms ND-GluRS ATPase

Ms ND-GluRS alone AVG
Ms ND-GluRS + Ms tRNA

y = 47.882 - 0.58304x R2= 0.99584
Gln

AVG
Gln

Ms ND-GluRS + Glu + Ms tRNA

2

y = 47.887 - 17.706x R = 0.99543
y = 47.877 - 16.432x R2= 0.99633
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G.

Ec LeuRS ATPase

Ec LeuRS alone AVG

y = 53.903 - 0.59764x R2= 0.99858

Ec LeuRS + Ec tRNA AVG

y = 53.909 - 35.947x R2= 0.99638

Ec LeuRS + Leu + Ec tRNA AVG

y = 53.9 - 34.513x R2= 0.99745

Ec LeuRS + Leu

y = 53.903 - 0.6365x R2= 0.99781
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H.

Ec ValRS ATPase

Ec ValRS alone AVG

y = 39.626 - 1.0123x R2= 0.99671

Ec ValRS + Ec tRNA AVG

y = 39.62 - 23.518x R2= 0.99725

Ec ValRS + Val + Ec tRNA AVG

y = 39.638 - 24.946x R2= 0.99423

Ec ValRS + Val

y = 39.625 - 0.73448x R2= 0.99232
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I.

Ec PheRS ATPase
2

Ec PheRS alone AVG

y = 37.649 - 0.57455x R = 0.99387

Ec PheRS + Ec tRNA AVG

y = 37.656 - 19.867x R2= 0.99276

Ec PheRS + Phe + Ec tRNA AVG

y = 37.648 - 18.415x R2= 0.99265

Ec PheRS + Phe

y = 37.649 - 0.5857x R2= 0.96322
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J.

Ec AlaRS ATPase

Ec AlaRS alone AVG

y = 53.818 - 0.4139x R2= 0.94967

Ec AlaRS + Ec tRNA AVG

y = 53.819 - 17.512x R2= 0.99425

Ec AlaRS + Ala + Ec tRNA AVG

y = 53.819 - 17.439x R2= 0.99759

Ec AlaRS + Ala

y = 53.819 - 0.21323x R2= 0.89818
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K.

Ec GlyRS ATPase
2

Ec GlyRS alone AVG

y = 47.346 - 0.43806x R = 0.98433

Ec GlyRS + Ec tRNA AVG

y = 47.348 - 17.08x R2= 0.9963

Ec GlyRS + Gly + Ec tRNA AVG

y = 47.345 - 17.304x R2= 0.99826

Ec GlyRS + Gly

y = 47.345 - 0.35718x R = 0.97335
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L.

Ec ThrRS ATPase

Ec ThrRS alone AVG

y = 49.318 - 1.8146x R2= 0.98388

Ec ThrRS + Ec tRNA AVG

y = 49.313 - 9.6175x R2= 0.98987

Ec ThrRS + Thr + Ec tRNA AVG

y = 49.314 - 11.938x R2= 0.99023

Ec ThrRS + Thr

y = 49.319 - 1.7929x R2= 0.99856
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M. Ec CysRS ATPase
Ec CysRS alone AVG

y = 50.996 - 1.645x R2= 0.99728

Ec CysRS + Ec tRNA AVG

y = 50.992 - 9.4932x R = 0.99066

Ec CysRS + Cys + Ec tRNA AVG

y = 51.002 - 10.757x R = 0.9926

Ec CysRS + Cys

y = 50.997 - 1.3252x R2= 0.99109
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N. Ec ProRS ATPase
Ec ProRS alone AVG

y = 43.679 - 0.48137x R2= 0.99214

Ec ProRS + Ec tRNA AVG

y = 43.687 - 10.632x R2= 0.99764

Ec ProRS + Pro + Ec tRNA AVG

y = 43.68 - 9.9627x R2= 0.98724

Ec ProRS + Pro

y = 43.68 - 1.2707x R2= 0.9944
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O.

Ec AspRS ATPase
2

Ec AspRS alone AVG

y = 51.993 - 0.25596x R = 0.96236

Ec AspRS + Ec tRNA AVG

y = 51.988 - 8.2662x R2= 0.99869

Ec AspRS + Asp + Ec tRNA AVG

y = 51.99 - 7.6918x R2= 0.99779

Ec AspRS + Asp

y = 51.993 - 0.13706x R2= 0.88533
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P.

Ec GlnRS ATPase

Ec GlnRS alone AVG

y = 71.682 - 1.9195x R2= 0.99159

Ec GlnRS + Ec tRNA AVG

y = 71.684 - 6.12x R2= 0.99515

Ec GlnRS + Gln + Ec tRNA AVG

y = 71.678 - 7.3206x R2= 0.9947

Ec GlnRS + Gln

y = 71.682 - 1.8311x R2= 0.98223
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Q.

Ec AsnRS ATPase

Ec AsnRS alone AVG

y = 67.767 - 1.869x R2= 0.98669

Ec AsnRS + Ec tRNA AVG

y = 67.77 - 5.9089x R2= 0.99348

Ec AsnRS + Asn + Ec tRNA AVG

y = 67.769 - 5.7779x R2= 0.99055

Ec AsnRS + Asn

y = 67.768 - 1.6575x R2= 0.98787
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R.

Ec ArgRS ATPase

Ec ArgRS alone AVG

y = 50.959 - 1.1655x R2= 0.9989

Ec ArgRS + Ec tRNA AVG

y = 50.964 - 6.5814x R2= 0.99004

Ec ArgRS + Arg + Ec tRNA AVG

y = 50.956 - 5.7001x R2= 0.99217

Ec ArgRS + Arg

y = 50.959 - 1.2871x R = 0.99338
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S.

Ec TyrRS ATPase

Ec TyrRS alone AVG

y = 45.865 - 0.16676x R2= 0.88014

Ec TyrRS + Ec tRNA AVG

y = 45.872 - 5.0757x R2= 0.99727

Ec TyrRS + Tyr + Ec tRNA AVG

y = 45.864 - 4.3045x R2= 0.99664

Ec TyrRS + Tyr

y = 45.866 - 0.20551x R2= 0.74042
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T.

Ec SerRS ATPase

Ec SerRS alone AVG

y = 46.72 - 0.24253x R2= 0.93842

Ec SerRS + Ec tRNA AVG

y = 46.715 - 3.8521x R2= 0.99674

Ec SerRS + Ser + Ec tRNA AVG

y = 46.724 - 3.6071x R2= 0.99762

Ec SerRS + Ser

y = 46.72 - 0.13775x R2= 0.91693
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U.

Ec IleRS ATPase
2

Ec IleRS alone AVG

y = 70.195 - 1.1172x R = 0.99826

Ec IleRS + Ec tRNA AVG

y = 70.198 - 2.9382x R2= 0.99017

Ec IleRS + Ile + Ec tRNA AVG

y = 70.187 - 2.6419x R = 0.98853

Ec IleRS + Ile

y = 70.195 - 1.1515x R = 0.99655
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V.

Ec TrpRS ATPase
2

Ec TrpRS alone AVG

y = 55.467 - 0.23077x R = 0.95051

Ec TrpRS + Ec tRNA AVG

y = 55.472 - 2.5644x R2= 0.99468

Ec TrpRS + Trp + Ec tRNA AVG

y = 55.466 - 2.3119x R2= 0.99437

Ec TrpRS + Trp

y = 55.467 - 0.19861x R2= 0.93503

60

50

NADH (µM)

40

30

20

10

0
0

1

2

3

Time (min)

4

5

115

W.

Ec MetRS ATPase

Ec MetRS alone AVG

y = 45.153 - 1.2974x R2= 0.9956

Ec MetRS + Ec tRNA AVG

y = 45.15 - 2.1041x R2= 0.99561

Ec MetRS + Met + Ec tRNA AVG

y = 45.155 - 2.4295x R2= 0.99648

Ec MetRS + Met

y = 45.152 - 1.4972x R = 0.97945
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X.

Ec GluRS ATPase

Ec GluRS alone AVG

y = 43.755 - 0.9029x R2= 0.99462

Ec GluRS + Ec tRNA AVG

y = 43.756 - 1.9039x R2= 0.99454

Ec GluRS + Glu + Ec tRNA AVG

y = 43.758 - 1.3592x R2= 0.98419

Ec GluRS + Glu

y = 43.756 - 1.3565x R2= 0.98258
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Y.

Ec HisRS ATPase
2

Ec HisRS alone AVG

y = 44.486 - 1.4096x R = 0.99512

Ec HisRS + Ec tRNA AVG

y = 44.482 - 1.8881x R = 0.99507

Ec HisRS + His + Ec tRNA AVG

y = 44.488 - 1.4396x R = 0.98265

Ec HisRS + His

y = 44.487 - 1.25x R2= 0.98129
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Z.

Ec LysRS ATPase

Ec LysRS alone AVG

y = 53.08 - 0.011753x R2= 0.12948

Ec LysRS + Ec tRNA AVG

y = 53.084 - 1.7821x R2= 0.98814

Ec LysRS + Lys + Ec tRNA AVG

y = 53.082 - 1.7538x R2= 0.99012

Ec LysRS + Lys

y = 53.08 + 0.0066728x R2= 0.0049152
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
5.1 Introduction
The work presented in this thesis focuses on enzymes involved in bacterial protein
translation. In Chapter 2, a novel enzyme from S. aureus, Sa2591, was investigated for
its involvement in indirect tRNA aminoacylation. In Chapter 3, the metal-binding domain
of Sa2591 was characterized and its enzymatic function in tRNA modification was
examined. In Chapter 4, a newly discovered activity of the aaRSs was presented and
possible functional roles of this activity were discussed.
The first step in protein translation requires the aaRSs, which catalyze the esterification
of their cognate amino acids onto their cognate tRNAs in an ATP-dependent manner,
producing AMP and PPi as side products (Figure 1.1 and 1.2) [1, 3]. These enzymes are
generally responsible for ensuring translational fidelity [1-3]. However, several bacteria
do not contain a full set of 20 aaRSs and therefore must use a two-step, indirect pathway
to aminoacylate some tRNAs [2, 4, 6, 7]. Many bacteria lack asparaginyl-tRNA synthetase
and/or glutaminyl-tRNA synthetase (AsnRS and/or GlnRS) and cannot directly produce
Asn-tRNAAsn or Gln-tRNAGln, respectively. In the absence of AsnRS or GlnRS, an indirect
pathway is used to aminoacylate these tRNAs [2, 6, 7]. The first step utilizes an NDAspRS or ND-GluRS, which have relaxed tRNA specificities and are able to aminoacylate
their cognate tRNA and specific non-cognate tRNAs with either aspartate or glutamate
e.g., ND-AspRS will produce Asp-tRNAAsp and Asp-tRNAAsn and ND-GluRS will produce
Glu-tRNAGlu and Glu-tRNAGln. In the second step of the indirect pathway the misacylated
intermediates, Asp-tRNAAsn and Glu-tRNAGln, are corrected by an amidotransferase
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called GatCAB. GatCAB uses glutamine as an ammonia donor for the transamidation of
Asp-tRNAAsn to Asn-tRNAAsn and Glu-tRNAGln to Gln-tRNAGln (Figure 1.3) [2, 4, 6-11].
The misacylated intermediates from the indirect tRNA aminoacylation pathway must
be prevented from entering the ribosome where they could cause translation errors at
asparagine and glutamine codons [13, 27, 28]. To this end, one mechanism utilizes the
formation of a ribonucleoprotein complex called the Asn-transamidosome [32-34]. In T.
thermophilus this structure is comprised of two ND-AspRS, two GatCAB, and 4 tRNAAsn
molecules, which allows for the efficient misacylation and transamidation of Asp-tRNAAsn,
while limiting its misuse by the ribosome (Figure 1.5) [32, 33]. An analogous structure
has not been found in H. pylori; instead the H. pylori Asn-transamidosome is tRNAindependent and assembles via a protein factor called, Hp0100 [34-36]. Our lab
discovered Hp0100 from a yeast two-hybrid assays that showed relevant connections to
both ND-AspRS and GatCAB (Figure 1.6) [37]. We demonstrated that Hp0100 is
necessary for H. pylori Asn-transamidosome assembly (Figure 1.7) and that Hp0100
increases the transamidation rate of Asp-tRNAAsn by GatCAB ~35-fold [34]. Dr. Gayathri
Silva has unpublished data showing that Hp0100 also increases the transamidation rate
of Glu-tRNAGn by GatCAB ~3-fold [38]. Hp0100 contains two distinct ATPase active sites
that are stimulated by different substrates: An AANH-like domain that is activated by GlutRNAGln and a P-loop domain that is activated by Asp-tRNAAsn (Figure 2.1) [38].
Full-length orthologs of Hp0100 are restricted to the e-proteobacteria however,
truncated versions are found outside of this clade. Chapters 2 and 3 focus on an ortholog
of Hp0100 from S. aureus called Sa2591. This ortholog is comprised of the first 2/3 of the
N-terminus of Hp0100 and contains both ATPase active sites, the AANH and P-loop
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domain (Figure 2.2 and 2.3). Since Sa2591 shares sequence and structural homology
with Hp0100, we wanted to investigate if Sa2591 is also an ATPase and determine its
involvement in indirect tRNA aminoacylation.
5.2 Sa2591 is a metalloprotein involved in indirect tRNA aminoacylation and is a
probable tRNA modification enzyme
The initial characterization of Sa2591 as a functional ortholog of Hp0100 is the main
focus of Chapter 2. When purifying Sa2591, we noticed that a co-purifying protein at the
molecular weight of E. coli D-AspRS (~66 kDa). Aminoacylation assays suggests that this
protein is E. coli D-AspRS (Figure 2.4), offering our first indication that Sa2591 is a
functional ortholog of Hp0100. We also investigated the ATPase activity of Sa2591 and
observed that its activity is only stimulated in the presence of misacylated tRNAs that
were expressed in vivo and are consequently post-transcriptionally modified (Figure 2.6);
misacylated tRNA transcripts were ineffective. The sequence, structural, and functional
similarities between Hp0100 and Sa2591 suggest that they are functional orthologs.
Future experiments would include investigating if Sa2591 is required for the formation of
a S. aureus Asn-transamidosome analogous to the H. pylori Asn-transamidosome.
Experiments are currently being conducted by Udumbara Rathnayake to see if Sa2591
increases the transamidation rates of Asp-tRNAAsn to Asn-tRNAAsn and Glu-tRNAGln to
Gln-tRNAGln by GatCAB. Future experiments also need to further characterize the impact
of modified versus transcribed tRNAs.
In our model structure of Sa2591, there are 5 conserved cysteines clustered together
near the P-loop ATPase domain, including a CXXC motif (Figure 3.2) [47]. Chapter 3
describes the characterization of this putative metal binding domain. In the initial
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characterization, several mono-, di-, and trivalent metals were screened and only Fe(II)
showed ligand binding (Figure 3.3). We then began a collaboration with Dr. Timothy
Stemmler to further study the Fe(II) binding of Sa2591. Dr. Stemmler has optimized a
Fe(II) competition binding assay that utilizes mag-fura-2, a metal chelator [78] (Figure
3.4). This assay was used to determine the stoichiometry of Fe(II) binding and the Kd
values of the binding event(s). Sa2591 preferentially binds 2 Fe(II) ions with estimated Kd
values of 4.5 ± 1.0 µM and 11.2 ± 3.7 µM (Figure 3.5). We also collected full Fe-XAS of
Sa2591 loaded with 2 Fe(II) ions. XANES confirmed the oxidation state of the bound irons
as Fe(II), and not Fe(III), and clearly demonstrate that the Fe(II) is in a symmetric sixcoordinate system with an octahedral geometry (Figure 3.6 and Table 3.1). EXAFS
showed that the Fe(II) center is bound to O/N ligands, without sulfur coordination in
contrast to our expectations from the model of Sa2591 (Figure 3.7 and Table 3.2). CD
spectroscopy showed that the secondary structure of Sa2591 did not change upon Fe(II)
binding (Figure 3.8 and Table 3.3).
Recently, through comparative genomics, Sa2591 was identified for its role in the
reduction of epoxyqueuosine to queuosine [48]. The authors renamed Sa2591 to QueH,
an epoxyqueuosine reductase [48]. We hypothesized that QueH would use the 2 Fe(II)
ions for this reduction. However, after testing several different reaction conditions, we did
not see any evidence of epoxyqueuosine reductase activity (Figure 3.9). These results,
along with the XAS data, prompted us to resubmit the S. aureus QueH sequence to ITASSER [47]. This time I-TASSER used a tRNA modifying enzyme, 2-thiouridine
synthetase (TtuA), to build the model of S. aureus QueH. Like QueH, TtuA contains a
CXXC motif near a P-loop ATPase domain. The crystal structure of TtuA revealed a [4Fe-
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4S] iron-sulfur cluster that is coordinated by its two cysteines in a CXXC motif and another
cysteine in the protein (Figure 3.10) [46]. The apparent structural similarities between
TtuA and QueH offer an explanation for why XAS did not show any coordination to sulfur
and why the epoxyqueuosine reductase assays were unsuccessful. It seems probable
that QueH requires an iron-sulfur cluster to reduce epoxyqueuosine to queuosine. Future
experiments would include reconstitution of an [4Fe-4S] iron-sulfur cluster and redoing
XAS, CD, and the epoxyqueuosine reductase assays.
Clearly, QueH appears to be a busy protein involved in multiple, different aspects of
tRNA biology, namely indirect tRNA aminoacylation and queuosine biosynthesis. We
hypothesize that QueH uses its two different activities under different growing
environments (Figure 5.1). Under robust growth conditions, QueH is used for stable
transamidosome complex formation, enhancing Asn-tRNAAsn biosynthesis and ensuring
accurate translation of asparagine codons. Under stress, QueH might leave the
transamidosome or simply fail to activate it, with two different results. First, the rate of
Asn-tRNAAsn biosynthesis will decrease, leading to aspartate insertion at asparagine
codons. This hypothesis is supported by the observation that mutations in M. smegmatis
GatCAB cause mistranslation of aspartate at asparagine codons, which resulted in a
adaptive phenotype that increased antibiotic tolerance [25, 26]. Second, dissociation or
deactivation of the transamidosome could allow QueH to turn on its epoxyqueuosine
reductase activity. This hypothesis is supported by growing evidence that the biosynthesis
of modified nucleotides in tRNA increases under stress-induced environments, especially
for modified nucleotides in the wobble position of the anticodon, where queuosine is
located [98]. Consistently, a study that investigated mRNA turnover in response to pH
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changes in S. aureus determined that QueH (Sa2591) mRNA transcripts increased during
acid-shock [99]. S. aureus QueH has proven to be a complicated protein that has several
different activities with the common theme of interacting with tRNA.
Asn-transamidosome complex formation
GatCAB
à Asn-tRNAAsn biosynthesis

QueH

ND-AspRS

Healthy growing
environment

QueH

Stressful growing
environment?
Asn-transamidosome disassembly

Queuosine biosynthesis increases

à Asp insertion
at Asn codons
ND-AspRS

GatCAB

+ 2 Fe2+ à Queuosine
biosynthesis
QueH

Figure 5.1. Schematic of our hypothesis that QueH is a multifunctional protein that
responds to stress. In a healthy growth environment, QueH would be required for the
stable formation of an Asn-transamidosome, which would increase Asn-tRNAAsn
biosynthesis and accurate translation. During stress, QueH would leave the
transamidosome (or stop activating it), which would cause accumulation of Asp-tRNAAsn,
resulting in Asp insertion at Asn codons. QueH would then use its epoxyqueuosine
reductase activity to increase queuosine biosynthesis.
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5.3 Many aminoacyl-tRNA synthetases produce ADP in the presence of deacylated
tRNAs
The aaRSs catalyze tRNA aminoacylation in an ATP dependent manner, releasing
AMP and PPi as side products. This reaction has long been understood and, to our
knowledge, production of ADP by the aaRSs has never been reported. In Chapter 4 of
this thesis, we demonstrated that many of the aaRSs can catalyze the hydrolysis of ATP
to ADP and Pi in the presence of deacylated tRNA.
We recently discovered this activity serendipitously when using H. pylori GluRS2 with
tRNAGln and glutamate to produce AMP as a positive control on a TLC (Figure 4.1). We
then tested for this activity with H. pylori GluRS1; here we observed that ADP production
is stimulated by deacylated tRNAs (Figure 4.2). To investigate if this activity is ubiquitous
among the aaRSs or restricted to those involved in indirect tRNA aminoacylation, 25
different aaRSs from 3 different bacterial species were screened for ADP production
including all 20 aaRSs from E. coli. Rates of ADP production varied by ~20-fold across
the aaRSs that were tested. Several comparisons can be made across the different
aaRSs and across different species. One of the most interesting observations is the
comparison of the 20 E. coli aaRSs across the different subclasses (Figure 4.5). The
aaRSs that most robustly produce ADP in the presence of deacylated tRNA belong in
subclasses Ia and IIa. It has been proposed that the aaRSs evolved in pairs across the
two classes, suggesting that ADP production might have evolved early in the evolution of
the aaRss [57, 87, 88]. Several other interesting comparisons of the rates of ADP
production were discussed in Chapter 4 as well as a few possible explanations for this
activity. There is the tantalizing possibility that this activity may be connected to bacterial

124
persister cell formation. There have been several recent reports that the intracellular ATP
concentration drops during persister formation, with a concomitant increase in ADP [9193]. Perhaps, when the concentration of deacylated tRNAs rises in the cell, indicating a
nutrient deficient environment, the aaRSs bind to the deacylated tRNA and begin to
hydrolyze ATP to ADP and Pi, causing the observed dro p in intracellular ATP.
Importantly, the ADP assays presented herein represent simple snapshots of ADP
production at single tRNA concentrations. Future experiments could include full kinetic
analyses for the ADP production with clearly defined tRNA concentrations. Another
interesting experiment would be to test non-cognate amino acids to see if there is a
connection to editing and ADP production.
5.4 Conclusions
In conclusion, this thesis describes two different research projects that both involved
tRNA aminoacylation. Chapters 2 and 3 focused on Sa2591, its role in indirect tRNA
aminoacylation, and its probable role in tRNA modification as an epoxyqueuosine
reductase. In chapter 4, we show a new activity of the aaRSs: that they are able to
produce ADP in the presence of deacylated tRNAs. This work demonstrates that while
these are old enzymes that have been studied for more than 6 decades there are still new
proteins and activities to be discovered.

125
REFERNCES
1. Dale T and Uhlenbeck OC (2005) Amino acid specificity in translation. Trends Biochem
Sci 30, 659-65.
2. Curnow AW, Hong K, Yuan R, Kim S, Martins O, Winkler W, Henkin TM and Soll D
(1997) Glu-tRNAGln amidotransferase: A novel heterotrimeric enzyme required for correct
decoding of glutamine codons during translation. Proc Natl Acad Sci USA 94, 1181911826.
3. Woese CR, Olsen GJ, Ibba M and Soll D (2000) Aminoacyl-tRNA synthetases, the
genetic code, and the evolutionary process. Microbiol Mol Biol Rev 64, 202-236.
4. Ibba M and Soll D (2000) Aminoacyl-tRNA synthesis. Annu Rev Biochem 69, 617-650.
5. Giege R and Springer M (2016) Aminoacyl-tRNA synthetases in the bacterial world.
EcoSal Plus 7.
6. Curnow AW, Ibba M and Soll D (1996) tRNA-dependent asparagine formation. Nature
382, 589-590.
7. Cathopoulis T, Chuawong P and Hendrickson TL (2007) Novel tRNA aminoacylation
mechanisms. Mol Biosyst 3, 408-18.
8. Becker HD and Kern D (1998) Thermus thermophilus: A link in evolution of the tRNAdependent amino acid amidation pathways. Proc Natl Acad Sci USA 95, 12832-12837.
9. Skouloubris S, Ribas de Pouplana L, De Reuse H and Hendrickson TL (2003) A
noncognate aminoacyl-tRNA synthetase that may resolve a missing link in protein
evolution. Proc Natl Acad Sci USA 100, 11297-302.

126
10. Lapointe J, Duplain L and Proulx M (1986) A single glutamyl-tRNA synthetase
aminoacylates tRNAGlu and tRNAGln in Bacillus subtilis and efficiently misacylates
Escherichia coli tRNAGln1 in vitro. J Bacteriol 165, 88-93.
11. Sheppard K, Akochy PM, Salazar JC and Soll D (2007) The Helicobacter pylori
amidotransferase GatCAB is equally efficient in glutamine-dependent transamidation of
Asp-tRNAAsn and Glu-tRNAGln. J Biol Chem 282, 11866-73.
12.

Tomb J, White O, Kerlavage AR, Clayton RA, Sutton GG, Fleishchmann RD,

Ketchum KA, Klenk HP, Gill S, Doughert BA et al. (1997) The complete genome sequence
of the gastric pathogen Helicobacter pylori. Nature 388, 539-547.
13.

Chuawong P and Hendrickson TL (2006) The nondiscriminating aspartyl-tRNA

synthetase from Helicobacter pylori: anticodon-binding domain mutations that impact
tRNA specificity and heterologous toxicity. Biochemistry 45, 8079-87.
14. Salazar JC, Ahel I, Orellana O, Tumbula-Hansen D, Krieger R, Daniels L and Soll D
(2003) Coevolution of an aminoacyl-tRNA synthetase with its tRNA substrates. Proc Natl
Acad Sci USA 100, 13863-8.
15. Min B, Pelaschier JT, Graham DE, Tumbula-Hansen D and Soll D (2002) Transfer
RNA-dependent amino acid biosynthesis: an essential route to asparagine formation.
Proc Natl Acad Sci USA 99, 2678-83.
16. Mladenova SR, Stein KR, Bartlett L and Sheppard K (2014) Relaxed tRNA specificity
of the Staphylococcus aureus aspartyl-tRNA synthetase enables RNA-dependent
asparagine biosynthesis. FEBS Lett 588, 1808-12.
17. Nakamura A, Yoa M, Chimnaronk S, Sakai N and Tanaka I (2006) Ammonia channel
couples glutaminase with transamidase reactions in GatCAB. Science 312, 1954-1958.

127
18. Weeks A, Lund L and Raushel F (2006) Tunneling of intermediates in enzymecatalyzed reactions. Curr Opin Chem Biol 10, 465-472.
19.

Huang X, Holden HM and RAushel FM (2001) Channeling of substrates and

intermediates in enzyme-catalyzed reactions. Annu Rev Biochem 70, 149-180.
20. Kang J, Kuroyanagi S, Akisada T, Hagiwara Y and Tateno M (2012) Unidirectional
Mechanistic Valved Mechanisms for Ammonia Transport in GatCAB. J Chem Theory
Comput 8, 649-60.
21. Zhao L, Dewage SW, Bell MJ, Chang KM, Fatma S, Joshi N, Silva G, Cisneros GA
and Hendrickson TL (2012) The kinase activity of the Helicobacter pylori AsptRNAAsn/Glu-tRNAGln amidotransferase is sensitive to distal mutations in its putative
ammonia tunnel. Biochemistry 51, 273-85.
22. Dewage SW and Cisneros GA (2015) Computational analysis of ammonia transfer
along two intramolecular tunnels in Staphylococcus aureus glutamine-dependent
amidotransferase (GatCAB). J Phys Chem B 119, 3669-77.
23. Zhao L, Rathnayake UM, Dewage SW, Wood WN, Veltri AJ, Cisneros GA and
Hendrickson TL (2016) Characterization of tunnel mutants reveals a catalytic step in
ammonia delivery by an aminoacyl-tRNA amidotransferase. FEBS Lett 590, 3122-32.
24. Rathnayake UM, Wood WN and Hendrickson TL (2017) Indirect tRNA aminoacylation
during accurate translation and phenotypic mistranslation. Curr Opin Chem Biol 41, 114122.
25. Su HW, Zhu JH, Li H, Cai RJ, Ealand C, Wang X, Chen YX, Kayani MU, Zhu TF,
Moradigaravand D et al. (2016) The essential mycobacterial amidotransferase GatCAB
is a modulator of specific translational fidelity. Nat Microbiol 1, 16147.

128
26. Javid B, Sorrentino F, Toosky M, Zheng W, Pinkham JT, Jain N, Pan M, Deighan P
and Rubin EJ (2014) Mycobacterial mistranslation is necessary and sufficient for
rifampicin phenotypic resistance. Proc Natl Acad Sci USA 111, 1132-7.
27. Min B, Kitabatake M, Polycarpo C, Pelaschier J, Raczniak G, Ruan B, Kobayashi H,
Namgoong S and Soll D (2003) Protein synthesis in Escherichia coli with mischarged
tRNA. J Bacteriol 185, 3524-3526.
28. Núñez H, Lefimil C, Min B, Söll D and Orellana O (2004) In vivo formation of glutamyltRNAGln in Escherichia coli by heterologous glutamyl-tRNA synthetases. FEBS Lett 557,
133-135.
29. Asahara H and Uhlenbeck OC (2005) Predicting the binding affinities of misacylated
tRNAs for Thermus thermophilus EF-Tu-GTP. Biochemistry 44, 11254-11261.
30. Roy H, Becker HD, Mazauric MH and Kern D (2007) Structural elements defining
elongation factor Tu mediated suppression of codon ambiguity. Nucleic Acids Res 35,
3420-30.
31. Cathopoulis TJT, Chuawong P and Hendrickson TL (2008) Conservred discrimination
against misacylated tRNAs by two mesophilic elongation factor tu orthologs. Biochemistry
47, 7610-7616.
32. Bailly M, Blaise M, Lorber B, Becker HD and Kern D (2007) The transamidosome: a
dynamic ribonucleoprotein particle dedicated to prokaryotic tRNA-dependent asparagine
biosynthesis. Mol Cell 28, 228-39.
33. Blaise M, Bailly M, Frechin M, Behrens MA, Fischer F, Oliveira CLP, Becker HD,
Pedersen JS, Thirup S and Kern D (2010) Crystal structure of a transfer-ribonucleoprotein
particle that promotes asparagine formation. EMBO J 29, 3118-3129.

129
34. Silva GN, Fatma S, Floyd AM, Fischer F, Chuawong P, Cruz AN, Simari RM, Joshi
N, Kern D and Hendrickson TL (2013) A tRNA-independent mechanism for
transamidosome assembly promotes aminoacyl-tRNA transamidation. J Biol Chem 288,
3816-22.
35. Huot JL, Fischer F, Corbeil J, Madore E, Lorber B, Diss G, Hendrickson TL, Kern D
and Lapointe J (2011) Gln-tRNAGln synthesis in a dynamic transamidosome from
Helicobacter pylori, where GluRS2 hydrolyzes excess Glu-tRNAGln. Nucleic Acids Res
39, 9306-15.
36. Fischer F, Huot JL, Lorber B, Diss G, Hendrickson TL, Becker HD, Lapointe J and
Kern D (2012) The asparagine-transamidosome from Helicobacter pylori: a dual-kinetic
mode in non-discriminating aspartyl-tRNA synthetase safeguards the genetic code.
Nucleic Acids Res 40, 4965-76.
37. Rain J, Selig L, De Reuse H, Battaglia V, Reverdy C, Simon S, Lenzen G, Petel F,
Wojcik J, Schachter V et al. (2001) The protein-protein interaction map of Helicobacter
pylori. Nature 409, 211-215.
38. Silva G (2014) Assembly And Function Of Macromolecular Complexes For Accurate
Trna Aminoacylation In Helicobacter Pylori, Wayne State University, Graduate School.
39. Marchler-Bauer A, Lu S, Anderson JB, Chitsaz F, Derbyshire MK, DeWeese-Scott
C, Fong JH, Geer LY, Geer RC, Gonzales NR et al. (2011) CDD: a Conserved Domain
Database for the functional annotation of proteins. Nucleic Acids Res 39, D225-9.
40. Rohl CA, Strauss EM, Misura KMS and Baker D (2004) Protein structure prediction
using rosetta. Methods Enzymol 383, 66-93.

130
41.

Lemke CT and Howell PL (2001) The 1.6 A crystal structure of E. coli

argininosuccinate synthetase suggests a conformational change during catalysis.
Structure 9, 1153-1164.
42. Goto M, Nakajima Y and Hirotsu K (2002) Crystal structure of argininosuccinate
synthetase from Thermus thermophilus HB8. Structural basis for the catalytic action. J
Biol Chem 277, 15890-6.
43. Leipe DD, Koonin EV and Aravind L (2003) Evolution and classification of P-loop
kinases and related proteins. J Mol Biol 333, 781-815.
44. Jager G, Leipuviene R, Pollard MG, Qian Q and Bjork GR (2004) The conserved
Cys-X1-X2-Cys motif present in the TtcA protein is required for the thiolation of cytidine
in position 32 of tRNA from Salmonella enterica serovar Typhimurium. J Bacteriol 186,
750-757.
45. Nakagawa H, Kuratani M, Goto-Ito S, Ito T, Katsura K, Terada T, Shirouzu M, Sekine
S, Shigi N and Yokoyama S (2013) Crystallographic and mutational studies on the tRNA
thiouridine synthetase TtuA. Proteins 81, 1232-44.
46. Chen M, Asai SI, Narai S, Nambu S, Omura N, Sakaguchi Y, Suzuki T, Ikeda-Saito
M, Watanabe K, Yao M et al. (2017) Biochemical and structural characterization of
oxygen-sensitive 2-thiouridine synthesis catalyzed by an iron-sulfur protein TtuA. Proc
Natl Acad Sci USA 114, 4954-4959.
47. Yang J, Yan R, Roy A, Xu D, Poisson J and Zhang Y (2015) The I-TASSER Suite:
protein structure and function prediction. Nat Methods 12, 7-8.

131
48. Zallot R, Ross R, Chen WH, Bruner SD, Limbach PA and de Crecy-Lagard V (2017)
Identification of a novel epoxyqueuosine reductase family by comparative genomics. ACS
Chem Biol 12, 844-851.
49. Vinayak M and Pathak C (2009) Queuosine modification of tRNA: its divergent role
in cellular machinery. Biosci Rep 30, 135-48.
50.

McCarty RM, Somogyi A, Lin G, Jacobsen NE and Bandarian V (2009) The

deazapurine biosynthetic pathway revealed: in vitro enzymatic synthesis of PreQ(0) from
guanosine 5'-triphosphate in four steps. Biochemistry 48, 3847-52.
51. Reader JS, Metzgar D, Schimmel P and de Crecy-Lagard V (2004) Identification of
four genes necessary for biosynthesis of the modified nucleoside queuosine. J Biol Chem
279, 6280-5.
52.

Miles ZD, McCarty RM, Molnar G and Bandarian V (2011) Discovery of

epoxyqueuosine (oQ) reductase reveals parallels between halorespiration and tRNA
modification. Proc Natl Acad Sci USA 108, 7368-7372.
53. Miles ZD, Myers WK, Kincannon WM, Britt RD and Bandarian V (2015) Biochemical
and spectroscopic studies of epoxyqueuosine reductase: A novel iron-sulfur cluster- and
cobalamin-containing protein involved in the biosynthesis of queuosine. Biochemistry 54,
4927-35.
54. Payne KA, Fisher K, Sjuts H, Dunstan MS, Bellina B, Johannissen L, Barran P, Hay
S, Rigby SE and Leys D (2015) Epoxyqueuosine reductase structure suggests a
mechanism for cobalamin-dependent tRNA modification. J Biol Chem 290, 27572-81.
55. Zheng C, Black KA and Dos Santos PC (2017) Diverse mechanisms of sulfur
decoration in bacterial tRNA and their cellular functions. Biomolecules 7.

132
56. Shigi N (2014) Biosynthesis and functions of sulfur modifications in tRNA. Front
Genet 5, 67.
57. Ribas de Pouplana L and Schimmel P (2001) Two classes of tRNA synthetases
suggested by sterically compatible dockings on tRNA acceptor stem. Cell 104, 191-193.
58. Bullwinkle TJ and Ibba M (2014) Emergence and evolution. Top Curr Chem 344, 4387.
59. Hou YM and Schimmel P (1988) A simple structural feature is a major determinant
of the identity of a transfer RNA. Nature 333, 140-5.
60. Cantara WA, Crain PF, Rozenski J, McCloskey JA, Harris KA, Zhang X, Vendeix FA,
Fabris D and Agris PF (2011) The RNA Modification Database, RNAMDB: 2011 update.
Nucleic Acids Res 39, D195-201.
61. Martinis SA and Boniecki MT (2010) The balance between pre- and post-transfer
editing in tRNA synthetases. FEBS Lett 584, 455-9.
62. Schmidt E and Schimmel P (1994) Mutational isolation of a sieve for editing in a
transfer RNA synthetase. Science 264, 265-7.
63. Nureki O, Vassylyev DG, Tateno M, Shimada A, Nakama T, Fukai S, Konno M,
Hendrickson TL, Schimmel P and Yokoyama S (1998) Enzyme structure with two catalytic
sites for double-sieve selection of substrate. Science 280, 578-82.
64. Hendrickson TL, Nomanbhoy TK, de Crecy-Lagard V, Fukai S, Nureki O, Yokoyama
S and Schimmel P (2002) Mutational separation of two pathways for editing by a class I
tRNA synthetase. Mol Cell 9, 353-62.
65. Putney SD and Schimmel P (1981) An aminoacyl tRNA synthetase binds to a specific
DNA sequence and regulates its gene transcription. Nature 291, 632-5.

133
66. Mayaux JF, Fayat G, Panvert M, Springer M, Grunberg-Manago M and Blanquet S
(1985) Control of phenylalanyl-tRNA synthetase genetic expression. Site-directed
mutagenesis of the pheS, T operon regulatory region in vitro. J Mol Biol 184, 31-44.
67. Putzer H, Laalami S, Brakhage AA, Condon C and Grunberg-Manago M (1995)
Aminoacyl-tRNA synthetase gene regulation in Bacillus subtilis: induction, repression and
growth-rate regulation. Mol Microbiol 16, 709-18.
68. Germain E, Castro-Roa D, Zenkin N and Gerdes K (2013) Molecular mechanism of
bacterial persistence by HipA. Mol Cell 52, 248-54.
69. Bullwinkle TJ and Ibba M (2016) Translation quality control is critical for bacterial
responses to amino acid stress. Proc Natl Acad Sci USA 113, 2252-7.
70. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A,
Aoki K-i, Nagai Y et al. (2001) Whole genome sequencing of meticillin-resistant
Staphylococcus aureus. Lancet 357, 1225-1240.
71. Sievert DM, Ricks P, Edwards JR, Schneider A, Patel J, Srinivasan A, Kallen A,
Limbago B, Fridkin S, National Healthcare Safety Network T et al. (2013) Antimicrobialresistant pathogens associated with healthcare-associated infections: summary of data
reported to the National Healthcare Safety Network at the Centers for Disease Control
and Prevention, 2009-2010. Infect Control Hosp Epidemiol 34, 1-14.
72. Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, Su J, Xu
F and Weinstock H (2013) Sexually transmitted infections among US women and men:
prevalence and incidence estimates, 2008. Sex Transm Dis 40, 187-93.
73. Altschul SF, Gish W, Miller W, Myers EW and Lipman DJ (1990) Basic local alignment
search tool. J Mol Biol 215, 403-10.

134
74. Gasteiger E, Hoogland C, Gattiker A, Duvaud S, Wilkins MR, Appel RD and Bairoch
A (2005) Protein identification and analysis tools on the ExPASy server in The Proteomics
Protocols Handbook (Walker, J. M., ed) pp. 571-607, Humana Press, New York.
75. Sampson JR and Uhlenbeck OC (1988) Biochemical and physical characterization
of an unmodified yeast phenylalanine transfer RNA transcribed in vitro. Proc Natl Acad
Sci USA 85, 1033-1037.
76. Fechter P, Rudinger J, Giege R and Theobald-Dietrich (1998) Ribozyme processed
tRNA transcripts with unfriendly internal promoter for T7 RNA polymerase: production and
activity. FEBS Lett 436, 99-103.
77. Sigma-Aldrich (2012) Beta-Nicotinamide adenine dinucleotide, reduced dipotassium
salt hydrate in Product Information (Sigma-Aldrich, ed)Sigma-Aldrich.
78. Rodrigues AV, Kandegedara A, Rotondo JA, Dancis A and Stemmler TL (2015) Iron
loading site on the Fe-S cluster assembly scaffold protein is distinct from the active site.
Biometals 28, 567-76.
79. University S (2019) Stanford Synchrotron Radiation Lightsource at the SLAC National
Accelerator Laboratory in
80. Cook JD, Bencze KZ, Jankovic AD, Crater AK, Busch CN, Bradley PB, Stemmler AJ,
Spaller MR and Stemmler TL (2006) Monomeric yeast frataxin is an iron-binding protein.
Biochemistry 45, 7767-77.
81. Dzul SP, Rocha AG, Rawat S, Kandegedara A, Kusowski A, Pain J, Murari A, Pain
D, Dancis A and Stemmler TL (2017) In vitro characterization of a novel Isu homologue
from Drosophila melanogaster for de novo FeS-cluster formation. Metallomics 9, 48-60.

135
82. Sreerama N and Woody RW (2004) On the analysis of membrane protein circular
dichroism spectra. Protein Sci 13, 100-12.
83. Frishman D and Argos P (1995) Knowledge-based protein secondary structure
assignment. Proteins: Structure, Function, and Genetics 23, 566-579.
84. Berg P (1956) Acyl adenylates: the interaction of adenosine triphosphate and Lmethionine. J Biol Chem 222, 1025-1034.
85. Hoagland MB, Stephenson ML, Scott JF, Hecht LI and Zamecink PC (1958) A soluble
ribonucleic acid intermediate in protein synthesis. J Biol Chem 231, 241-257.
86. Kemp BE, Benjamini E and Krebs EG (1976) Synthetic hexapeptide substrates and
inhibitors of 3':5'-cyclic AMP-dependent protein kinase. Proc Natl Acad Sci USA 73, 103842.
87. Carter CW, Jr. (2017) Coding of class I and II aminoacyl-tRNA synthetases. Adv Exp
Med Biol 966, 103-148.
88. Rodin SN and Ohno S (1995) Two types of aminoacyl-tRNA synthetases could be
originally encoded by complementary strands of the same nucleic acid. Orig Life Evol
Biosph 25, 565-89.
89. Hauryliuk V, Atkinson GC, Murakami KS, Tenson T and Gerdes K (2015) Recent
functional insights into the role of (p)ppGpp in bacterial physiology. Nat Rev Microbiol 13,
298-309.
90. Lewis K (2007) Persister cells, dormancy and infectious disease. Nat Rev Microbiol
5, 48-56.
91. Cameron DR, Shan Y, Zalis EA, Isabella V and Lewis K (2018) A genetic determinant
of presister cell formation in bacterial pathogens. J Bacteriol 200, e00303-18.

136
92. Conlon BP, Rowe SE, Gandt AB, Nuxoll AS, Donegan NP, Zalis EA, Clair G, Adkins
JN, Cheung AL and Lewis K (2016) Persister formation in Staphylococcus aureus is
associated with ATP depletion. Nat Microbiol 1.
93. Shan Y, Gandt AB, Rowe SE, Deisinger JP, Conlon BP and Lewis K (2017) ATPdependent persister formation in Escherichia coli. mBio 8, e02267-16.
94. Shimizu Y, Inoue A, Tomari Y, Suzuki T, Yokogawa T, Nishikawa K and Ueda T
(2001) Cell-free translation reconstituted with purified components Nat Biotechnol 19,
751-755.
95. Uter NT, Gruic-Sovulj I and Perona JJ (2005) Amino acid-dependent transfer RNA
affinity in a class I aminoacyl-tRNA synthetase. J Biol Chem 280, 23966-77.
96. Shiba K and Schimmel P (1992) Functional assembly of a randomly cleaved protein.
Proc Natl Acad Sci USA 89, 1880-1884.
97. Banerjee P, Warf MB and Alexander R (2009) Effect of a domain-spanning disulfide
on aminoacyl-tRNA synthetase activity. Biochemistry 48, 10113-10119.
98.

Chan C, Pham P, Dedon PC and Begley TJ (2018) Lifestyle modifications:

coordinating the tRNA epitranscriptome with codon bias to adapt translation during stress
responses. Genome Biol 19, 228.
99. Anderson KL, Roux CM, Olson MW, Luong TT, Lee CY, Olson R and Dunman PM
(2010) Characterizing the effects of inorganic acid and alkaline shock on the
Staphylococcus aureus transcriptome and messenger RNA turnover. FEMS Immunol
Med Microbiol 60, 208-50.

137
ABSTRACT
TRNA AMINOACYLATION: NEW PROTEIN PLAYERS AND NEW REACTIONS
by
WHITNEY N. WOOD
May 2019
Advisor: Dr. Tamara L. Hendrickson
Major: Chemistry (Biochemistry)
Degree: Doctor of Philosophy
Protein translation must usually occur with high accuracy for an organism to survive.
However, Helicobacter pylori, Staphylococcus aureus, and many other microorganisms
including important human pathogens, lack one or more aminoacyl-tRNA synthetase
(aaRS), the enzymes that typically aminoacylate tRNAs for ribosomal translation. These
organisms must use an indirect pathway to aminoacylate some tRNAs. Specifically, H.
pylori lacks the genes that encode for asparaginyl- and glutaminyl-tRNA synthetases
(AsnRS and GlnRS, respectively). Instead, H. pylori uses a two-step, indirect pathway to
synthesize Asn-tRNAAsn and Gln-tRNAGln. This process requires two misacylating tRNA
synthetases (a non-discriminating aspartyl-tRNA synthetase, ND-AspRS, and a
misacylating glutamyl-tRNA synthetase 2, GluRS2) and a glutamine-dependent
amidotransferase called GatCAB. We have recently discovered a protein called Hp0100
that promotes formation of a stable complex between ND-AspRS, Hp0100, and GatCAB
called the Asn-transamidosome. Hp0100 enhances GatCAB’s ability to produce both
Asn-tRNAAsn and Gln-tRNAGln and it hydrolyzes ATP in the presence of either AsptRNAAsn or Glu-tRNAGln, the precursors to Asn-tRNAAsn and Gln-tRNAGln, respectively.
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(Red text indicates misacylation.) This dissertation focuses on three different research
projects. Chapter 2 describes our evaluation of a shortened ortholog of Hp0100 from S.
aureus. Full-length orthologs of Hp0100 are restricted to the e-proteobacteria; however,
we have recently discovered truncated orthologs comprising the N-terminal 2/3 of Hp0100
outside of this clade. The truncated ortholog from S. aureus (Sa2591) is compared to
Hp0100 to assess if it is a functional ortholog of Hp0100. The predicated model structure
of Sa2591 showed several conserved cysteine residues clustered together with a CXXC
motif next to one of the ATPase active sites. Chapter 3 focuses on our characterization
of this putative metal-binding site and Sa2591’s potential involvement in the synthesis of
a tRNA modification. Chapter 4 reports our discovery that some aaRSs hydrolyze ATP to
ADP in the presence of tRNA. All aminoacyl-tRNA synthetases (aaRSs) catalyze the ATPdependent aminoacylation of tRNAs, producing AMP and PPi as side products. We are
unaware of any evidence that aaRSs can produce ADP instead of AMP. We characterized
this activity in 25 different aaRSs and propose a function for ADP formation.
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